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Introduction
Cells consume energy for basic household 
tasks and specialized functions. Biosynthesis 
of proteins and nucleic acids, transport of 
ions across membranes for electric activity, 
intracellular transport of proteins, RNAs 
and organelles, locomotive and contractile 
processes are prominent examples of energy 
consuming events. Also in the cybernetics of 
a cell, that is, the control of gene expression 
and signaling, a small but significant amount 
of energy is continuously invested. 
Carbohydrates and lipids are the main 
chemical sources of cellular energy. Amino 
acids in protein may also be used as energy 
source. Nutrient molecules are taken up by the 
cell from the environment through dedicated 
transport systems. Once in the cell they serve 
in anabolic processes as building blocks for 
macromolecular constituents or as precursors 
of intermediate metabolites. The majority of 
the energy content of especially fatty acids and 
glucose is, however, transformed in catabolic 
pathways to a high-energy compound called 
adenosine 5’-triphosphate, abbreviated as 
ATP. ATP may be considered as the universal 
energy currency of cells: virtually all energy 
demanding processes use ATP directly or 
indirectly as an energy source by hydrolyzing 
it to ADP and inorganic phosphate. 
Oxidative phosphorylation, often abbreviated 
as OXPHOS, is the catabolic pathway 
responsible for most ATP production. Glycolysis 
also produces ATP but its ATP yield is only 
about 1/18th of oxidative phosphorylation. 
OXPHOS uses energy contained in reduced 
cofactors called NADH and FADH2 to convert 
ADP to ATP and in the process reduces dioxygen 
(O2) to water. Most of the NADH and FADH2 
is produced in the tricarboxylic acid cycle (also 
called TCA-, Krebs or Citric Acid  cycle) and 
fatty acid β-oxidation. The doorway to the TCA 
cycle for all fuel-molecules: sugars, fat and 
proteins, is acetyl coenzyme A and both the TCA 
cycle and fatty acid β-oxidation and OXPHOS 
itself take place in the mitochondria.
Evidently, mitochondria take a central 
position in energy metabolism and often they 
are referred to as the powerhouse of the cell 
(1). Obviously, failure of the powerhouse is 
detrimental to the cell. It inevitably leads to 
loss of cell function and death. 
This truism is rightfully used to explain late 
cellular events in diseases with a mitochondrial 
etiology. Also in physiological aging, failure of 
the cell’s powerhouse is alleged as etiological. 
The truism, however, gives no insight in the 
molecular processes that initiate and amplify 
mitochondrial dysfunction, nor does it pinpoint 
leads for therapeutic intervention.
Mitochondria are involved in multiple other 
processes besides energy production, such 
as apoptosis through an intricate regulation 
of cytochrome c release by pro- and anti-
apoptopic factors, the regulation of cytosolic 
calcium concentrations, metabolism of fatty 
acids and some amino acids, iron homeostasis 
and cholesterol/steroid biosynthesis (2). The 
undermining of the various processes involving 
mitochondrial functions may lead to disease. 
In contrast to the other cytoplasmic organelles, 
mitochondria contain their own DNA in 
multiple copies. This mitochondrial DNA 
(mtDNA) is essential for OXPHOS function 
and mutations in mtDNA can lead to disease. 
Diseases with mtDNA mutation in their 
etiology are remarkable in that they display 
a high phenotypical diversity. This is counter 
intuitive when realizing that all pathogenic 
mtDNA mutations lead to respiratory defects 
at some point, it might therefore be expected 
that their phenotypical presentation would be 
similar. A point in case is made by the A3243G 
mtDNA mutation. This is a mutation in the 
mitochondrial tRNA(UUR)-leucine gene (MTTL-
1) that is associated with syndromic and non-
syndromic phenotypes with as many as 61 
clinical manifestations documented (3). 
To explain the wide spectrum of clinical 
expression, mtDNA mutation accumulation 
by segregation as well as dominant-negative 
effects of aberrant mtDNA products on 
the mitochondrial-nuclear crosstalk have 
been proposed, but the mechanisms remain 
essentially undisclosed. 
This thesis attempts to contribute to disclosing 
such mechanisms by investigating segregation 
mechanisms and identifying nuclear genes that 
alter expression under A3243G mutational 
mitochondrial dysfunction. Starting off with 
a brief view on origin of mitochondria, a 
number of aspects of mitochondrial genetics, 
disease and cell biology of relevance for the 
experimental chapters of this thesis are briefly 
highlighted in the next paragraphs.
Origin of mitochondria 
It is a well accepted evolutionary view that 
mitochondria result from a prokaryotic 
symbiosis of a fermenting cell producing 
ATP only by substrate level phosphorylation 
as in glycolysis and a cell capable of much 
more efficient ATP production by coupling 
respiration to ADP phosphorylation.  The 
former is envisioned to have engulfed the 
latter by an endocytotic process. The double 
membrane appearance of mitochondria upon 
electron microscopical examination, presence 
of DNA, sensitivity of mitochondrial protein 
synthesis to prokaryotic translation inhibitors, 
similarities of the mitochondrial inner 
membrane lipid composition and bacterial 
membranes are among the popular arguments 
for the endosymbiotic view (4), which is 
confirmed by modern comparative genomics 
(5;6). Comparative mtDNA genomics across 
eukaryotes presents the view of mtDNA being 
structurally very diverse, but well-conserved 
and limited in genetic function. It contributes 
invariably to mitochondrial protein synthesis 
and oxidative phosphorylation and occasionally 
to transcription and protein import (7). 
The origin and evolution of the mitochondrial 
protein content is under active study. The 
proteome of the ancestral endosymbiont 
appears to have undergone major changes in 
protein content by extensive losses and gains as 
assessed by comparative, mass-spectrometry 
based proteomics (8). It is remarkable that in 
the evolutionary process of shaping eukaryotic 
mitochondria a tiny fraction of the ancestral 
genome with very limited and universally 
conserved functions resisted elimination.
Mitochondrial DNA
The double stranded, circular mitochondrial 
human mtDNA of 16.569 basepair is densely 
packed with genetic information (figure 1) 
and occurs in 100s to 1000s of copies per 
cell. The only non-coding part of ~ 1 kb (the 
D-loop) is highly polymorphic and the target 
of demographic and forensic mtDNA studies. 
mtDNA encodes 13 proteins of the ~90 that 
make up the 5 protein Complexes of the 
oxidative phosphorylation system (figure 2). 
Figure 1: Mitochondrial DNA
The mitochondrial DNA is a circular, double 
stranded molecule of 16.569 basepairs, most of 
which are coding. Next to the 13 OXPHOS protein 
genes it contains the sequences for 2 rRNAs and 
22 tRNAs as indicated. The A3243G mutation is 
located in the tRNA leucine (UUR) gene, note 
that there is a second tRNA leucine gene present 
(CUN). The D-loop is the only non-coding part of 
the mtDNA, which is highly variable and contains 
the center of origin for replication of the heavy 
chain (OH) and the transcription start sites of both 
the heavy and light chain (PH and PL).
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Noteworthy, only Complex II is fully encoded 
by the nuclear genome. mtDNA also codes 
22 tRNAs and 2 rRNAs which function in 
translation of the mtDNA encoded proteins. All 
other OXPHOS proteins and factors needed for 
mitochondrial protein synthesis are nuclear 
encoded and imported from the cytoplasm. 
The same holds true for factors involved 
in mtDNA replication and transcription. It 
is beyond the scope of this thesis to review 
mtDNA transcription (9), translation (10), 
repair (11) and replication (12). However it is 
of importance to note that mtDNA replication 
is relaxed, that is, it occurs independent of 
the nuclear DNA synthesis phase and that it 
is in constant turnover (13). In post-mitotic 
cells also extensive mtDNA turnover occurs 
and based on available half life data of 2 – 10 
days (14;15), it can be calculated that in a life-
time of a neuron or cardiomyocyte its mtDNA 
content is refreshed approximately 1500 to 
15.000 times.
Due to inefficient mtDNA repair mechanisms 
(11) and a mutagenic oxidative environment 
constituted by the nearby location of the 
respiratory chain, mtDNA experiences high 
mutation rates. mtDNA mutation rates are 
on average 5-10 times higher compared to 
nuclear DNA, but hotspots exist. Today there 
are hundreds of point mutations, deletions 
and rearrangements in mtDNA known, many 
of them associated with disease (see www.
mitomap.org).
As said a cell may contain hundreds to 
thousands copies of mtDNA and a sequence 
variant (or mutant form) can therefore co-exist 
with the original sequence. The occurrence 
of both wild type and mutant mtDNA in one 
cell is called heteroplasmy as opposed to 
homoplasmy. The (pathogenic) mutation load 
can reach percentages up to 80 percent or 
more without any perceptible malfunction of 
the cell (16;17), although the actual threshold 
varies per cell type and mutation. Thus wild 
type mtDNAs can compensate mutants to a 
large extent. The importance of understanding 
mechanisms that lead to mtDNA mutation 
accumulation resulting in failure of oxidative 
phosphorylation will be evident. 
Figure 2: Scheme of oxidative phosphorylation 
Oxidative phosphorylation can be divided in two parts, electron transport through the respiratory 
chain and parallel proton pumping, and the formation of a high-energy bond by phosphorylation of 
ADP to ATP employing the energy contained in the electrochemical proton gradient. The respiratory 
chain consists of 4 complexes which contain multiple subunits, most of which are nuclear encoded. 
Note that complex II does not contain any mitochondrial DNA encoded subunits. The mitochondrial 
encoded proteins are indicated in the figure as is the flow of electrons and hydrogen ions through the 
different complexes. The generation of ATP takes place in complex V.
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Maternal inheritance and random 
segregation in germ line and soma
Sperm mtDNA is rapidly eliminated after 
fertilization (19). Consequently, mtDNA 
inheritance is indeed maternal in virtually all 
conceptions (20). Because of the absence of a 
paternal partner recombination of mtDNA 
does not occur in the germ line. When a female 
transmits two mtDNA variants to the zygote, 
the cells descending from the heteroplasmic 
primordial germ cell that differentiate to 
primary oocytes undergo random segregation 
of the maternal mtDNA alleles. Along with 
a reduction in mtDNA copy number this is 
assumed to lead to a large increase in the 
variance of heteroplasmy in the mature oocytes 
and consequently offspring (21). This mtDNA 
genetic bottleneck elegantly explains why in 
the mammalian population homoplasmy is the 
norm and heteroplasmy rare. It leads to fixation 
of either of the mtDNA alleles in only a few or 
even one organismal generation, contributing 
to characteristic demographic distribution of 
mtDNA haplogroups and exposing new non-
neutral sequence variants homogenously to 
evolutionary forces (22). 
Non-neutral mtDNA mutations are under 
positive or negative selection. Positive 
selection may contribute to climatic 
adaptation. Conversely, negative selection 
eliminates deleterious mutations from the 
population. It is thus random mitotic mtDNA 
segregation (see box) and negative selection 
that is assumed to purge deleterious mtDNA, 
with rate of random segregation (and purging) 
being primarily determined by mtDNA copy 
number in the female germ line. Recently it has 
become clear however, that in the germ line of 
mice mtDNA segregation may not go hand in 
hand with strong copy number reduction (23). 
Thus, other mechanisms than random mtDNA 
segregation may underlie rapid generational 
mtDNA variant changes. 
Also in the soma, random (mitotic) segregation 
is thought to be the norm. However, a multitude 
of clinical investigation and heteroplasmy 
mouse model studies with naturally occurring 
neutral mtDNA mutations, unambiguously 
show that there are notable exceptions to 
the presumed rule of random segregation in 
somatic cells (24;25).
Box: Illustration of random segregation; the hypergeometric distribution
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mtDNA is organized in nucleoids 
In recent years it has become evident that 
mtDNA does not occur in mitochondria as naked 
molecules (26). Several mtDNA molecules 
form a complex with a set of proteins, of which 
mitochondrial transcription factor A (TFAM) 
is the most abundant and, next to its role as 
a transcription factor,  seems to function in 
a similar way as the histones do for nuclear 
DNA in that it packages mtDNA (27). Other 
proteins in the mtDNA-protein complexes 
known as nucleoids are identified and include 
mitochondrial single-stranded DNA-binding 
protein (mtSSB), polymerase γ and the DNA 
helicase Twinkle (28). The number of mtDNA 
molecules and the actual shape and molecular 
composition of the nucleoids remain uncertain. 
Two publications give an indication for the 
number of mtDNAs per nucleoid: it should be 
around 2 to 10 in human cells (29;30).
At the next higher level of mtDNA genome 
organization may reside the mitochondrial 
compartment. Its morphological appearance 
as many fragmented mitochondria, as a single 
tubular reticulum or intermediates, is highly 
dynamic and dictated by the balance of the 
activities of nuclear encoded mitochondrial 
fusion and fission genes (see page 14). 
In conclusion, it is not a collection of freely 
diffusing single mtDNA molecules that 
constitute the mtDNA segregation unit. Rather, 
there appear two levels of organizational 
complexity of mtDNA genome segregation, 
the nucleoid and the dynamic mitochondrial 
compartment. 
mtDNA and disease
Mitochondrial diseases afflict ~1 in 5000 of the 
human population (31), part of which are caused 
by inherited mitochondrial DNA mutations. 
In addition, healthy individuals acquire 
mtDNA mutations during life, contributing 
to such common ageing phenomena as muscle 
weakness and neuro-degeneration. 
Since all pathogenic mtDNA mutations lead to 
respiratory defects at some point, it might be 
expected that their phenotypical representation 
would be similar. On the contrary, however, 
there is great clinical variance among mtDNA 
diseases, with many characterized by tissue-
specific defects (32). An important feature of 
mitochondrial DNA disease is the threshold 
effect: a biochemical defect e.g. as measured 
by oxygen consumption becomes overt only 
after the percentage of mutation exceeds a 
given threshold. Typically, the consumption of 
oxygen, which is an indication for the amount of 
ATP produced by the mitochondria, decreases 
tenfold if the cells carry over approximately 80 
percent mutated mtDNA (16), though actual 
thresholds may vary . 
Understanding the molecular mechanisms 
which control the level of mutant mtDNA 
and the ensuing pathobiochemistry obviously 
is an important aspect to understanding 
mitochondrial and ageing diseases, as far as 
mtDNA is involved in the latter. Spreading 
and accumulation of mtDNA mutations by 
segregation in cells and tissues may underlie 
mtDNA disease variability, but mechanisms 
are elusive.
Segregation leading to mutation accumulation 
above threshold and loss of OXPHOS may as 
such be able to explain mtDNA diseases with 
a heteroplasmy degree exceeding the 80-90% 
threshold, as for instance in patients with 
the phenotype of mitochondrial myopathy, 
encephalopathy, lactic acidosis, and stroke-like 
episodes (MELAS; OMIM 540000) in which the 
A3243G mutation studied in this thesis was 
first discovered (33;34). Segregation however 
fails to explain pathogenesis of the maternally 
inherited diabetes and deafness phenotype of 
the A3243G mutation (MIDD; OMIM 520000). 
MIDD is a type of diabetes (contributing 
~5%) which resembles mostly type II diabetes 
without the obese appearance. It is a maternally 
transmitted disease with an average age-of-
onset of 38 years and the glucose intolerance 
is caused by impaired insulin secretion of the 
pancreas, but the relevant tissue, pancreatic β-
cells, contains only moderate levels of mutation 
load (35), far from the ~80 % threshold 
levels required for mitochondrial OXPHOS 
dysfunction. A dominant negative gain-of-
function would explain the lack of threshold 
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effect seen in this case. The tRNA(UUR)-leucine 
mutation could lead to dominantly acting, 
qualitative translation defects like amino acid 
mis-incorporation or premature translation 
termination products directing synthesis of 
a set of aberrant translation products (36). 
Such dominant acting factors could by e.g. 
reprogramming the nuclear transcriptional 
program, lead to β-cell dysfunction.
mtDNA and aging
The phenotypes of mitochondrial DNA 
diseases often resemble diseases of the elderly 
(deafness, muscle weakness, diabetes, neuro-
degeneration, cardiomyopathy), implying 
mtDNA mutation in aging. For many 
decades the vicious circle theory of somatic 
accumulation of mtDNAs has dominated the 
mtDNA aging literature. It states that a first 
somatically acquired mtDNA mutation ignites 
a self-amplifying process of mitochondrial ROS 
generation, oxidative mtDNA mutation and 
deleterious oxidative protein modification. It 
predicts that in a single cell, random mtDNA 
mutations will accumulate exponentially with 
age. Formally never proven and lingering 
in scientific literature, recent experimental 
evidence now strongly defy this view. 
First, single cell analyses of mitotic and post-
mitotic tissues of healthy, aged individuals 
show that in individual (Cytochrome c 
oxidase negative) cells of a given tissue (brain 
(37;38), muscle (39), colon mucosa (40), kidney 
(41), cardiomyocytes (42), accumulation 
of unique, not random, mtDNA mutations 
occurs. Second, model system studies 
with the mtDNA mutator mice (mice with 
proofreading-deficient polymerase γ), which 
dramatically and prematurely replicates 
physiological aging, do not show exponential 
mtDNA accumulation (43;44). They do show 
increased apoptosis (45), in line with notion 
of reduction of organ function with aging. 
What transpires is that clonal accumulation 
of unique mtDNA mutations acquired  early 
in development  through mtDNA replication 
errors or mitochondrial ROS, appears to be a 
significant contributor to physiological aging. 
Morphological dynamics of mitochondria
By light microscopy mitochondria can 
be observed in unstained living cells as 
filamentous or grain like structures. These 
appearances underlie their etymology. 
The word mitochondrion is derived from 
the Greek words for thread (mito) and 
grain (chondro). Major developments in 
fluorescence microscopy and in vivo staining 
nowadays enables a much more detailed 
view on organelle dynamics and motility of 
molecular constituents. Particularly the use 
of lipophilic, cationic fluorescent dyes (which 
accumulate in well functioning mitochondria 
due to the electrochemical proton gradient) 
and expression of mitochondrially targeted 
auto-fluorescent proteins in combination 
with sophisticated fluorescence microscopy 
techniques, led to the contemporary view that 
the mitochondrial compartment is dynamic, 
not only in terms of shape, size, motion and 
number of mitochondria, but also in terms 
of fusion and fission and mobility of intra-
mitochondrial molecules. It is overtly clear 
now that the balance between the activity 
of fusion and fission proteins determines 
the actual morphology of the mitochondrial 
compartment. Depending on cell type and 
stage, many distinct, individual mitochondria, 
a single continuous mitochondrion of 
filamentous shape and any intermediate state 
can thus be found (46). The mitochondrial 
GTPases Mitofusin 1 and 2 and Opa1 are now 
well established as mediators of mitochondrial 
fusion (47). Mitochondrial fission is mediated 
by Drp1, another mitochondrial GTPase of the 
dynamin family
Microscopic Fluorescence Recovery After 
Photobleaching (FRAP) experiments 
permit to analyze diffusion parameters 
of macromolecules in living cells. Such 
experiments with mitochondrially targeted 
auto-fluorescent proteins showed their 
extensive intra-mitochondrial diffusion (48).
It follows naturally from the above that 
cells have the potential to homogenize their 
mitochondrial compartments among which is 
mtDNA. 
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Indeed, cells deprived of mitochondrial fusion 
genes do not mix their reporter contents as 
shown by elegant cell fusion experiments 
with mfn-/- and mfn+/+ embryonic mouse 
cells differentially labeled with permanent 
mitochondrial markers (49) By sampling 
synchronized cells in time, the morphology 
of mitochondria has been found to oscillate 
between the reticular and fragmented state in a 
cell cycle dependent manner (50). Mitochondria 
of cells in mid-interphase appear as a tubular 
network (figure 3), whereas shortly before, 
during and after mitosis the mitochondrial 
mass is fragmented. It is this fragmentation 
that ensures that daughter cells get their 
share of mitochondria, including mtDNA. 
Electron microscopy and conventional electron 
microscopical contrast techniques provide a 
view that is quite familiar to many researchers. 
Healthy mitochondria viewed through an 
electron microscope look at first sight like oval-
shaped forms, grain-like indeed, which appear 
covered with stripes. On detailed inspection, 
a two membrane system becomes usually 
obvious. What is well known as the outer 
membrane lines the oval shape, whereas the 
heavily folded inner membrane is responsible 
for the stripes, known as cristae. The two 
membranes clearly define sub-mitochondrial 
compartments: the inter membrane space and 
the mitochondrial matrix. Of note in normally 
functioning mitochondria, linear cristae are 
seen while aberrant patterns such as circular 
or concentric ring pattern are an indication 
of dysfunction. The popularity of electron 
microscopic images of mitochondria may have 
contributed to the long held, but incorrect 
view that they occur as distinct and individual 
organelles each containing their own mtDNA, 
instead of the dynamic network which the 
mitochondria actually form.
Figure 3: Mitochondrial morphology assessed by enzyme-cytochemical staining 
Using exogenous cytochrome c as substrate Cytochrome c oxidase (COX) in these fixed cells has 
converted diaminobenzidine tetrahydrochloride (DAB) into a brown reaction product which is visible. 
The shape of the functional mitochondria becomes visible, either as fragments or a tubular network.
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Scope of this thesis 
In the Introduction of this thesis it is argued 
that tissue–specific mtDNA segregation and 
dominant negative effects of mtDNA mutations 
may underlie variable disease expression of 
A3243G mutant mtDNA. These two aspects 
have been investigated in the experimental 
chapters of this thesis. Chapters 2 and 3 deal 
with mtDNA segregation analysis. Specifically, 
Chapter 2 describes two methodologies that 
were key to the experiments of Chapter 3, 
where the role of nucleoids in segregation has 
been analyzed.
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Introduction
As a norm all mtDNA molecules in all cells 
of an individual have identical sequences, a 
situation referred to as homoplasmy (1). Due 
to lack of sophisticated DNA repair systems 
in the mitochondrial compartment, mutation 
rates of mtDNA are 5 to 10 times higher 
than nuclear DNA and deviation from the 
norm of homoplasmy will inevitably occur 
by acquisition of mtDNA mutation. Thus, 
invariably the situation arises where two 
mtDNA sequence variants are present within 
cells of individuals, a condition referred to as 
heteroplasmy. Whether inherited or acquired, 
as a consequence of segregation, deleterious 
mtDNA mutations can accumulate to a level 
(the critical threshold) at which too little 
compensation from the wild-type molecules 
occurs, accounting for cell and tissue failure 
and hence disease.
Studies with mice that are heteroplasmic 
for neutral mtDNA haplotypes contributed 
significantly to establishment of the germ line 
mitochondrial genetic bottleneck: reduction of 
the mtDNA copy number in early oogenesis in 
combination with random segregation leading 
to return to homoplasmy in one or only a few 
generations (2). Recently, however, it has been 
suggested that actual mtDNA copy numbers 
in early oogenesis are not compatible with 
the genetic bottle neck/random segregation 
mechanism (3). Also with heteroplasmic mice 
it has been shown that post-natally, tissue-
specific non-random or directional segregation 
occurs (4). Furthermore, in human post-
embryonic life non-random segregation of 
inherited, pathogenic mtDNA mutations 
occurs (5;6). Gaining further knowledge of 
segregation mechanisms will thus contribute 
to better understanding of the nature of the 
mitochondrial genetic bottleneck and clonal 
accumulation of acquired mtDNA mutation 
with age, and how differences in pathogenic 
mtDNA mutation load among different tissues 
and organs are generated.
So-called transmitochondrial cybrids are 
created by fusion of enucleated cells carrying 
two different mtDNA sequence variants 
with a nucleated cell that has no mtDNA (ρ0 
cells). Heteroplasmic cybrid cells have been 
a valuable source for experimental mitotic 
segregation studies. In the human situation, 
they have been particularly used to study 
segregation of the A3243G mtDNA sequence 
variants. This mutation causes a variety of 
disease phenotypes. It may be considered as 
exemplary for a central question in diseases 
with mtDNA mutation in their etiology: 
How can a single mutation causes variable 
phenotypes? Segregation is an obvious, but 
elusive factor (7). 
By heteroplasmy analysis of bulk DNA 
of passages of cybrid clones carrying the 
A3243G pathogenic mutation stable various 
patterns have been found heteroplasmy and 
heteroplasmy shifts to either wild-type or 
mutant (for review, see Enriquez (1)). Of 
significance, stable heteroplasmy as measured 
on bulk DNA of cells in passages of cultured 
cybrid clone can be the result of random mitotic 
mtDNA segregation or non-segregation. Single 
Abstract 
Segregation of mtDNA is an important underlying pathogenic factor in mtDNA mutation 
accumulation in mitochondrial diseases and aging, but the molecular mechanisms of mtDNA 
segregation are elusive. Lack of high-throughput single cell mutation load assays lies at the base 
of the rareness of studies in which, at the single cell level, mitotic mtDNA segregation patterns 
have been analyzed. Here we describe development of a novel fluorescence-based, non-gel PCR-
RFLP method for single cell A3243G mtDNA mutation load measurement. Results correlated 
very well with a quantitative in situ Padlock/Rolling Circle Amplification based genotyping 
method. In view of the throughput and accuracy of both methods for single cell A3243G mtDNA 
mutation load determination, we conclude that they are well suited for segregation analysis.
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cell heteroplasmy determinations are needed 
to discriminate the two, but such studies are 
rare. Lehtinen et al. used limiting dilution 
to clone cells of late passages of continuously 
cultured A3243G cybrid founder cells. 
Following limited outgrowth, the mutation 
load of individual cells in the passages was 
assessed from bulk DNA using a PCR-RFLP 
method with gel electrophoresis to quantify 
mutant fractions (8). 
The workload associated with the gel-based 
PCR-RFLP method for A3243G single cell 
heteroplasmy quantification after limited 
clonal expansion of cells in cybrid clone 
passages limits throughput. As an illustration, 
a total of 6 clones have been analyzed after 30 
weeks of continuous culture with on average 
~33 single cells analyzed (range 22-63) (8;9). We 
therefore sought to develop high-throughput 
A3243G mutation-load assays enabling 
analysis of hundreds of single cells in long 
term serial passages of multiple cybrid clones. 
This will enable analysis of heteroplasmy 
evolution longitudinally which is essential 
in mechanistically sorting out segregation 
processes that determine heteroplasmy.
Here we used two strategies for single cell 
A3243G mtDNA mutation load quantization: i) 
physical isolation of individual cells by single 
cell sorting, followed by closed-tube, real-time 
fluorescence PCR load measurement and ii) 
bi-color in situ mtDNA genotyping by Padlock/
rolling circle amplification (Padlock-RCA, 
(10;11)) in combination with image analysis 
for quantification purposes. 
In preliminary experiments with Taqman 
and Molecular Beacon probes for closed-tube, 
real-time fluorescence read-out, it was found, 
however, that the mutant probes reported 
both mutant and wild type targets. Similar 
observations have been reported by Bai et 
al. (12). This poor discriminatory power 
is likely a consequence of the unfavorable 
thermodynamics associated with G-T 
mismatches. It complicates closed-tube assays 
anyhow, but is further exacerbated in this 
particular case, because the mutation locates 
in a GC-rich environment which, being in the 
D-loop of the mitochondrial tRNALeu(UUR), 
is additionally poised to form secondary 
structures. 
With PCR-RFLP being a sturdy and time-
honored approach for A3243G mutant 
detection, we thus resorted to non-gel based 
PCR-RFLP fragment analyses employing 
melting temperature characteristics (PCR-
RFMT) of the fragments using SybrGreen as 
reporter. The only sacrifice to a closed-tube 
assay is the one-time addition of the restriction 
enzyme. Here we describe the development 
and performance of the PCR-RFMT method. 
Recently, we described qualitative in situ 
genotyping of the 3243 locus by Padlock-
RCA (10). Here we applied dedicated image 
analysis (13) to quantitatively correlate the 
in situ assay with the PCR-RFMT. Based on 
their specifications in terms of throughput 
and accuracy, we conclude that both methods 
are suitable for A3243G mtDNA segregation 
analyses.
 Materials and methods
Cells, cell culture and cell sorting
The A3243G transmitochondrial 143B cybrid 
clones were grown on Dulbecco’s Modified 
Eagle’s medium containing 4.5 mg/ml glucose 
and 110 µg/ml pyruvate (DMEM) supplemented 
with 50 µg/ml uridine and 10% fetal bovine 
serum. Transmitochondrial cybrids used in 
this work were sampled from an ongoing 
mtDNA segregation study in which we cloned 
heteroplasmic cells, expanded them to 9-cm 
cultures, following continuously culture with 
a 10% split twice a week. Cybrid cells were 
produced by fusing skin fibroblasts from two 
maternally inherited diabetes and deafness, 
MIDD, patients (coded V and GB) with 143B 
ρ0 cells. For single cell sorting, cells at near-
confluence were harvested in 2 ml trypsin/
EDTA. 500 µl was resuspended in a 5 ml Falcon 
tube containing 1500 µl complete medium. 
Single cells were sorted in the wells of an 
optical 96-wells plate (Abgene, UK) with the 
FACSVantage SE (BD, USA) cell sorter using 
forward and side scatter gating. Plates were 
sealed and stored with no further processing 
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at -20°C for at least one night up to several 
months.
For in situ genotyping cells of a given clone 
and passage number were harvested by 
trypsin treatment and seeded in a culture 
plate containing microscopic object slides. 
Cells were allowed to adhere overnight after 
which they were fixed for in situ genotyping 
with Padlock-RCA
Primers, probes and PCR
The primers for the PCR-RFMT were 
designed with PrimerExpress version 1.0 
and were manufactured at Eurogentec, 
Belgium. The first forward primer 5’-
CGCCTTCCCCCGAAATGAT anneals 
from location 3162 to 3181 on the 
mtDNA. The second forward primer 5’-
CCCACACCCACCCAAGAACA anneals from 
location 3204 to 3223 and the common reverse 
primer 5’-TGGCCATGGGTATGTTGTTA at 
3300-3319. The first forward and the common 
reverse primers are referred to as primer 
pair A and the other pair as primer pair B. 
PCR was performed in an end-volume of 20 
µl, containing 10 µl SYBRGreen Mastermix 
(Applied Biosystems, USA) and 250 nM of both 
primers. The PCR begins with 10 minutes hot-
start at 95°C, followed by 42 cycles alternating 
between 15 seconds 95°C and 1 minute 63°C 
using an ABI 7700 or 7900 spectrofluorometric 
Thermal Cycler (Applied Biosystems, USA).
Restriction enzyme digestion and melt 
analysis
For restriction enzyme digestion of the 
amplicons, 5 µl ApaI restriction enzyme mix 
was added directly to the PCR product. The 
enzyme mix was composed of 0.5 µl BSA (10 
mg/ml), 0.5 µl 10 x buffer A (Promega, the 
Netherlands), 50 nl ApaI enzyme (80 U/µl, 
Promega) and 4 µl of water. Digestion was 
performed overnight at 37°C and stored at 4°C 
until further processing up to a few weeks. 
The melt curves were recorded with an ABI-
Prism 7700 or 7500 spectrofluorimetric 
Thermal Cycler (Applied Biosystems, USA) by 
gradually increasing the temperature during 
20 minutes from 65°C to 90°C. The ABI-Prism 
software package did not include software for 
baseline correction and peak area calculations. 
In order to perform automated analysis and 
data plotting, melt data were exported in 
Excel file format and a macro was developed 
in house, as described in the Results Section.
genotyping mtDNA at the 3243 
locus in situ and image analysis
In situ mtDNA genotyping by Padlock-
RCA was performed as described previously 
(Larsson et al. (10)) with slight modifications. 
In short, cells grown on microscopic object 
slides were fixed in 4% formaldehyde and 
0.5% sucrose in PBS for 20 minutes at ambient 
temperature, washed with PBS and stored 
in 70% ethanol at 4°C. Following extensive 
rinses with PBS they were treated with 0.05% 
pepsin (Sigma, P7000) in 0.01 M HCl during 
5 minutes to gain access to the mtDNA for 
enzymes and Padlock probes. Next, the cells 
were dehydrated with graded ethanol series 
followed by a pre-incubation of 15 minutes in 
the enzyme reaction buffer supplemented with 
0.2 µg/µl BSA. Then, MscI (0.5 U/µl) and T7 
exonuclease (10 U/µl) (New England Biolabs, 
USA) were added and incubated at 37°C 
at the specified times.  After digestion and 
exonuclease treatment, the Padlock probes 
(100 nM) were hybridized and circularized 
simultaneously. The hybridization/ligation 
was performed for one hour at 55°C with 
Ampligase (Epicentre, USA) in the supplied 
buffer supplemented with 1 mM NAD+, 10% 
glycerol and 125 mM KCl. Subsequently, the 
cells were washed with TBS supplemented 
with 0.05% Tween-20. RCA was performed 
for 1 hour at 37 °C after addition of 1 U/µl of 
Φ29 DNA polymerase (Fermentas, Canada) 
and 0.2 mg/ml histone (Sigma, type 2A, Calf 
Thymus), to condense the RCA DNA product. 
For hybridization of the detection probes we 
used 250 nM Lin16-FITC for the wild type 
mtDNA and 250 nM Lin33-Cy5 for the A3243G 
mtDNA (Larsson et al. (10)). Incubation was for 
30 minutes at 37°C in 2x SSC supplemented 
with 20% formamide. Following 3 washes with 
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Tris buffered saline, 0.01 % Tween-20, nuclear 
DNA was counterstained with 4’,6-Diamidino-
2-phenylindole (DAPI).
For digital microscopy a computer-controlled 
standard epi-fluorescence microscope (Leica 
DM) equipped with a 100 W mercury arc lamp, 
a 100 X 1.3 N.A. objective and a scientific grade 
16-bit CCD camera are used. The computer 
controls image acquisition through a motorized 
8-position filter-block rotor and shutters.
The image analysis algorithm has as the key 
feature that it segments cells in the absence 
of a cytoplasmic counter stain. Instead, 
cytoplasm delineation is based on a fixed radial 
distance from each cell nucleus, a strategy 
made possible due to the absence of Padlock-
RCA signals outside the cytoplasm (Allalou 
et al. (13)). The program runs as a plug-in for 
the VIS Image Analysis Software (Visiopharm, 
Denmark). The number of red (Cy5) over the 
number of red (Cy5) plus green (FITC) signals 
per cell is taken as the mutation load.
Results
Development of the sybrgreen PCR-RFMT 
method
As measures of the mutant and wild type 
A3243G fractions in the single cell PCR 
products, we used the areas under the peaks 
of the first derivative of the SybrGreen 
fluorescence melting curve of the ApaI 
fragmented PCR product. Figure 1A presents 
relevant optimization experiments with two 
different primer pairs for amplification of the 
A3243G region and ~100 pg genomic DNA 
from cybrid clones that were 100% wild type 
and near 100% mutant. A heteroplasmic 
sample was also included in this experiment.
Primer pair A generates a 158 bp long 
fragment with 43% GC and a Tm of 79°C. 
Digestion with the restriction enzyme 
ApaI cleaves only the mutant amplicon 
into a piece of 83 bp ( 46% GC, Tm = 76°C) 
and a piece of 75 bp (40% GC, Tm = 74°C). 
Primer pair B generates a 116 bp long 
fragment with 45% GC and also a Tm of 79°C. 
Digestion with the restriction enzyme ApaI 
cleaves the mutant amplicon into a piece of 41 
bp and 54% GC and a piece of 75 bp and 40% 
GC, both with a Tm of 74°C. These Tm’s are 
measured in the PCR solution containing the 
restriction buffer and enzyme. In absence of 
the restriction enzyme mix, the (undigested) 
amplicon melts at a temperature of 77°C.
Figure 1 Electrophoretic and melt characteristics of the PCR-RFLP fragments. 
(A) Gel electrophoresis of the restriction enzyme fragments obtained after ApaI digestion of PCR 
products obtained with primer sets A and B. The amount of input DNA was ~ 100 pg DNA, the 
equivalent of ~ 16 cells. Products in lane 1 and 4 are from homoplasmic wild type cybrid cells (0% 
mutant), lanes 3 and 6 from homoplasmic mutant cells (100% mutant) and lanes 2 and 5 from a 
heteroplasmic cybrid cell clone. 
(B) Derivatives of the melting curves of homoplasmic A3243G mtDNA. The top graph in (B) corresponds 
to lane 1 and 3 of Fig 1A, the bottom graph to lanes 4 and 6. The curves represent the derivative of 
the SYBR Green signal intensity (y-axis) as a function of temperature (x-axis). 
Note that the two mutant fragments generated with primer set A do not resolve electrophoretically 
(lane 3 in Fig 1A) while they do so in the melt analysis. The two mutant fragments generated with 
primer set B, in contrast, resolve electrophoretically (lane 6 in Fig 1A) but not in the melt analysis. 
The Tm of both mutant fragments is ~74°C. 
Single cell A3243G mtDNA mutation load assays for segregation analyses chapter 2
2
Figure 2 Single cell PCR-RFMT analysis. 
Upper panel: Melt curves of PCR-amplified ApaI digested DNA from two homoplasmic (I: wt; II: 
A3243G) and one heteroplasmic (III) A3243G mtDNA cybrid cell. Lower panel: Examples of derivative 
melt curves and their analysis. The experimental data (black line) are processed by an Excel macro 
to generate baseline corrected peaks (grey line) from which the mutant peak fraction is determined. 
Roman numbers refer to the melt curves in the upper panel. The remaining 6 plots represent the 
analysis of single cybrid cells derived from two patients, GB and V.
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The electrophoretic behavior of the PCR-
RFLP fragments generated from the genomic 
DNA of the three clones in a 3% agarose gel 
is shown in figure 1A while figure 1B shows 
the derivatives of the fluorescent melting 
curves of the homoplasmic DNAs. The mutant 
restriction fragments of the amplicon from 
primer pair A do not resolve electrophoretically, 
but do so in the melt analysis. Conversely, the 
mutant fragments of primer pair B do resolve 
electrophoretically but do not in the melt 
analysis. Note also that with primer pair B the 
wild-type fragment is much better separated 
from the mutant fragments in the melt 
analysis compared to primer pair A. The near-
perfect co-incidence of the melt peaks of the 
mutant fragments of primer pair B, the bell-
shapes of both peaks and their near complete 
separation provide an excellent starting point 
for baseline correction and estimation of 
the peak areas as measures for the mutant 
and wild type fractions. Primer pair B was 
therefore chosen for further development.
To evaluate the performance of the PCR-RFMT 
at the single cell level we sorted single cells from 
various passages of heteroplasmic cybrid clones 
in 96-well optical plates and performed the 
PCR-RFMT procedure. In Figure 2 melt curves 
are shown for a heteroplasmic cell and two cells 
with different homoplasmic states (top panel), 
as well as 9 derivative curves (lower panel). 
To exclude incomplete ApaI digestion under 
PCR-RFMT conditions, we mixed 100 % wild-
type and 100 % mutant cell, single cell sorted 
them and performed PCR-RMFT. Only wild 
type and mutant melt curves were obtained. 
The results led us to conclude that also at 
the single cell level the PCR-RFMT principle 
works. To automatically measure the areas 
under the peaks and process the data into 
suitable plots we next developed a macro 
in Excel. The macro searches for the two 
maxima and the minimum between the two 
peaks. It then employs the bell-shapes of the 
peaks for baseline correction. The right-hand 
flank of the mutant peak (from mutant peak 
position to the minimum between the peaks) 
is mirrored to the left and the line connecting 
the base of the bell is used as baseline. 
Similarly, the left-hand flank of the wild type 
peak is mirrored to the right and baseline 
corrected. Base-line corrected peaks for 6 
A3243G cybrid cells are plotted in the graphs 
(Figure 2, lower panel). Finally, the macro 
calculates mutation load from the areas under 
the peaks. The data from a complete 96-wells 
plate are plotted both as a histogram as well 
as a scatter plot as a function of Ct (threshold 
Cycle) value for easy evaluation of the results. 
We next compared the single cell PCR-RFMT 
approach with traditional gel-based imaging 
and quantification of fragments. For this we used 
single cell PCR-RFLP fragments that by RFMT 
analysis showed a wide range of heteroplasmy. 
The correlation proved to be good (Figure 3).
The correlation between the analysis methods 
may be good, but both methods likely suffer 
from underestimation of the mutant fraction 
due to heteroduplex formation and the 
inability of ApaI to digest heteroduplexes. To 
Figure 3 Correlation between A3243G mtDNA 
gel-based RFLP and PCR-RFMT analysis at the 
single cell level. 
Individually sorted cells were subjected to PCR-
RFMT analysis followed by gel electrophoresis and 
image analysis of the same samples.
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analyze the magnitude of this problem and to 
eventually mathematically compensate for this 
phenomenon, we cloned wild type and mutant 
fragments, prepared mixtures of purified wild-
type and mutant plasmids, and submitted 
them to PCR-RFMT analysis at various 
dilutions down to the sub-attomol range. If 
p represents the wild type and q the mutant 
fraction in the sample then, at maximum 
heteroduplex formation, the relation between 
the wild type homoduplex-, heteroduplex- and 
mutant homoduplex fractions and the original 
input fractions are given by the equation: p2 + 
2pq + q2 = 1. Thus, the mutation load q may be 
derived from the square root of the cleavable 
fraction q2, since both p2 and pq are not 
recognized by ApaI. Figure 4 plots the expected 
mutant fraction against the square root of 
the mutant peak fraction. The good linear 
relationship between expected mutation load 
and the square root of the mutant peak fraction 
shows that full heteroduplex formation occurs, 
enabling mathematical corrections to be made. 
Image analysis of in situ genotyped 
heteroplasmic A3243G cybrid cells and 
correlation with PCR-RFMT.
Previously, we developed an in situ A3243G 
mtDNA genotyping method. It is based on 
target primed, rolling circle amplification of 
in situ hybridized and ligated Padlock probes 
(10). The exquisite sensitivity of the ligase 
reaction to mismatches confers high specificity 
to A3243G sequence variant detection, not 
achievable by hybridization based methods 
such as Taqman, while the signal generation 
capacity of rolling circle amplification provides 
single molecule detection sensitivity with 
standard fluorescence microscopy and virtually 
no background signals. Results are primarily 
judged visually, but image analysis can 
confer quantitative information. We therefore 
recently developed dedicated image analysis 
software to quantify Padlock-RCA mtDNA 
signals in cells (13). Here we apply quantitative 
Padlock-RCA and correlate results with RFMT 
analysis. Figure 5A presents the mutation 
load histograms of cells from a given passage 
of clone GB_20 measured with the PCR-RFMT 
and the quantitative Padlock-RCA technique. 
For PCR-RFMT 6 independently processed, 
single cell sorted 96-well plates were analyzed 
resulting in the mutation load histogram of 
541 cells in Figure 5A. The peak average was 
92.2% with a standard deviation of 3.4%. For 
Padlock-RCA with 458 cells analyzed from the 
same GB_20 clone passage. The peak average 
was 92.5% with a standard deviation of 4.3%. 
Images of Padlock-RCA of a co-culture of 
homoplasmic wild-type and mutant cybrids, 
and GB_20 clone are shown in Figure 5B and 
5C, respectively.
Discussion
In our segregation study we aim to measure 
mtDNA point mutation levels in individual 
members of cell populations with a priori 
unknown intercellular variability in mutation 
load reasons. We may thus expect relatively 
low accuracies in view of the high specificity 
and sensitivity demanded. Throughput is then 
obviously an important issue to get statistically 
Figure 4 Heteroduplex formation during A3243G 
PCR-RFMT analysis. 
mtDNA from a heteroplasmic cybrid cell line 
was cloned into a plasmid vector. Plasmids 
containing either wild-type or mutant mtDNA 
sequences clones were identified, purified and 
mixed in predetermined ratios. Data are plotted 
as input mutation load (x-axis) versus the square 
root of the mutant peak fraction as measured by 
PCR-RFMT. Error-bars are the standard deviation 
of three measurements per data point.
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Figure 5 Correlating single cell A3243G mtDNA PCR-RFMT with Padlock-RCA. 
(A) Individual cells of a heteroplasmic A3243G clone (GB_20) were analyzed by PCR-RFMT (n = 541) 
and Padlock-RCA (n = 458). According to computer simulations of random segregation, the very 
great majority of the cells in this late passage should have been genetically fixed, i.e. be homoplasmic 
mutant. (B)(C) Photomicrographs of cells from respectively a co-culture of wild-type and mutant 
cybrids, and the heteroplasmic GB_20 clone genotyped in situ by Padlock-RCA (630x). Red dots 
correspond to mutant and green dots to wild-type mtDNA
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sound data for biologically mechanistic 
interpretation.
We describe here development, performance 
and correlation of two single cell mutation 
load assays, based on different principles, for 
mtDNA segregation analysis.
In their current versions both methods perform 
about equally in terms of throughput: 100s of 
cells per person per day. Increase in throughput 
can be achieved by further automation 
by e.g. for RFMT-PCR robotized PCR and 
melt analysis. Use of 384-well plates would 
quadruple throughput of the PCR-RFMT but 
unfortunately single cell sorting is limited to 96-
well plates. For padlock-RCA image acquisition 
has been identified as the rate-limiting factor, 
thus automation of microscopy and image 
acquisition will increase throughput. In terms 
of analytical accuracy differences exist. PCR-
RFMT suffers of heteroduplex formation. 
Mathematical correction allows in principle 
the true mutation load to be determined, the 
square root relationship between found and 
true mutation level values leads to great 
inaccuracies in the 0 - 25 % range, indeed the 
reason why ‘last hot’ cycle methodology has 
been introduced. We note that the PCR-RFMT 
methodology has been developed for segregation 
analysis, not for clinical diagnosis of A3243G 
mtDNA mutation loads in, for example, blood 
samples. For the latter low level heteroplasmy 
detection is needed, likely because many cells 
in the sample will not carry mutant mtDNA. 
However, in pathophysiological studies with 
(microdissected) patient biopsy material of 
MELAS patients, the PCR-RFMT method 
likely will be a convenient alternative to 
conventional PCR-RFLP because it tends to be 
enriched in the A3243G mutation (20;21). 
Padlock RCA is free of heteroduplex formation 
problems and in principle will have the same 
accuracy over the full heteroplasmy range. 
A point of concern may be that efficiencies 
of detection are likely low as they are in 
conventional FISH with extremely small 
targets. Cells that are low in mtDNA copy 
number and low in heteroplasmy levels may 
then be falsely classified as homoplasmic.
The results in figure 5A are interesting from 
an analytical and segregation mechanistic 
point of view. They originate from cell of a 
late passage. PCR RFMT results of earlier 
passages of this clone were near-identical (to 
be reported elsewhere). Computer simulations 
of random mtDNA segregation specified to 
this clone clearly indicated that at passage 
15 segregation should have been obvious, by 
flatting of the peak and the appearance of 
homoplasmic mutant cells. It thus appears 
that this clone (and several others not shown 
here) displays the phenomenon of stable 
heteroplasmy first reported by Lehtinen. If 
truly so, then variance in mutation load due 
to biology of segregation is absent and the 
variance observed in heteroplasmy is due to 
assay variability. 
In the high mutant load range tested, both 
our methods perform equally well analytically 
with standard deviations of 3% in RFMT and 
4% in RCA at n = 400. At decreasing mutation 
levels the padlock-RCA method will likely 
maintain accuracy while the PCR-RFMT will 
lose accuracy particularly below 25%. 
In conclusion, we have developed single cell 
A3243G mtDNA mutation loads assays that 
meet the needs of segregation studies. 
Acknowledegements 
This work was supported by the LUMC 
Matching Fund, the Prinses Beatrix Fonds 
and the EC-Strep Project ENLIGHT.
The authors wish to thank Visiopharm, 
Denmark, for a free license and help with 
integration of new functionality in VIS.
30
References
 1.  Enriquez,J.A. (2003) Segregation and dynamics of mitochondrial DNA in mammalian cells. In Holt,I.J. 
(ed.), Genetics of Mitochondrial Diseases. Oxford University Press, Oxford, pp. 279-294.
 2.  Jenuth,J.P., Peterson,A.C., Fu,K. and Shoubridge,E.A. (1996) Random genetic drift in the female 
germline explains the rapid segregation of mammalian mitochondrial DNA. Nat.Genet., 14, 146-
151.
 3.  Cao,L., Shitara,H., Horii,T., Nagao,Y., Imai,H., Abe,K., Hara,T., Hayashi,J.I. and Yonekawa,H. (2007) 
The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ 
cells. Nat. Genet., 39, 386-390
 4.  Jenuth,J.P., Peterson,A.C. and Shoubridge,E.A. (1997) Tissue-specific selection for different mtDNA 
genotypes in heteroplasmic mice. Nat.Genet., 16, 93-95.
 5.  Chinnery,P.F., Zwijnenburg,P.J., Walker,M., Howell,N., Taylor,R.W., Lightowlers,R.N., Bindoff,L. and 
Turnbull,D.M. (1999) Nonrandom tissue distribution of mutant mtDNA. Am.J.Med.Genet., 85, 498-
501.
 6.  Chinnery,P.F. (2002) Modulating heteroplasmy. Trends Genet., 18, 173-176.
 7.  Torroni,A., Campos,Y., Rengo,C., Sellitto,D., Achilli,A., Magri,C., Semino,O., Garcia,A., Jara,P., 
Arenas,J. et al. (2003) Mitochondrial DNA haplogroups do not play a role in the variable phenotypic 
presentation of the A3243G mutation. Am.J.Hum.Genet., 72, 1005-1012.
 8.  Lehtinen,S.K., Hance,N., El Meziane,A., Juhola,M.K., Juhola,K.M., Karhu,R., Spelbrink,J.N., Holt,I.J. and 
Jacobs,H.T. (2000) Genotypic stability, segregation and selection in heteroplasmic human cell lines 
containing np 3243 mutant mtDNA. Genetics, 154, 363-380.
 9.  Turner,C.J., Granycome,C., Hurst,R., Pohler,E., Juhola,M.K., Juhola,M.I., Jacobs,H.T., Sutherland,L. 
and Holt,I.J. (2005) Systematic segregation to mutant mitochondrial DNA and accompanying loss of 
mitochondrial DNA in human NT2 teratocarcinoma Cybrids. Genetics, 170, 1879-1885.
 10.  Larsson,C., Koch,J., Nygren,A., Janssen,G., Raap,A.K., Landegren,U. and Nilsson,M. (2004) In situ 
genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock 
probes. Nat.Methods, 1, 227-232.
 11.  Nilsson,M. (2006) Lock and roll: single-molecule genotyping in situ using padlock probes and rolling-
circle amplification. Histochem.Cell Biol., 126, 159-164.
 12.  Bai,R.K. and Wong,L.J. (2004) Detection and quantification of heteroplasmic mutant mitochondrial 
DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step 
approach. Clin.Chem., 50, 996-1001.
 13.  Allalou,A., van de Rijke,F.M., Jahangir Tafrechi,R.S., Raap,A.K. and Wahlby,C. (2007) Image based 
measurements of single cell mtDNA mutation load. In: Image Analysis; Lecture Notes in Computer 
Science Vol 4522 pp 631-640. Springer Berlin/Heidelberg
Single cell A3243G mtDNA mutation load assays for segregation analyses chapter 2
31
32
Suppressed and quantal mtDNA segregation chapter 3
33
3
Suppressed and quantal mtDNA segregation in 
heteroplasmic cell cultures 
Roshan S. Jahangir Tafrechi*, Frans M. van de Rijke*, Karoly Szuhai*, Rene F. M. de Coo§, 
Harsha Karur Rajasimha◊, Mats Nilsson°, Patrick F. Chinnery‡, David C. Samuels◊, 
George M.C. Janssen* and Anton K. Raap*
*Department of Molecular Cell Biology, Leiden University Medical Center, P.O. Box 9503, 2300 
RA Leiden, The Netherlands 
§Department of Molecular Cell Biology and Genetics, Maastricht University, PO Box 1475, 6201 
BL Maastricht, The Netherlands,
◊Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, 
Blacksburg, USA
‡Department of Neurology, University of Newcastle upon Tyne, UK
° Department of Genetics and Pathology, The Rudbeck Laboratory, Uppsala, Sweden
34
Suppressed and quantal mtDNA segregation chapter 3
3
Introduction
When two neutral mtDNA alleles are present 
in the founding cell of a clone, the process of 
random mitotic segregation leads to genetic 
drift and ultimately to genetic fixation of 
mtDNA alleles in descendant cells. Two 
homoplasmic cell populations will eventually 
emerge with the proportion of their sizes, 
reflecting the mutation load in the founding 
cell (1). The lower the mtDNA copy number, 
the more rapid cells will emerge that have 
homoplasmic mtDNA, as illustrated in figure 
1. mtDNA genetic drift is not  only driven by 
mitosis, but also by mtDNA turnover (2;3).
In case of heteroplasmy with a deleterious 
mutation, cells drifting towards homoplasmy 
for the mutant allele can therefore acquire 
merely on stochastic grounds high levels 
of the deleterious mtDNA. Up to a point at 
which the critical threshold heteroplasmy is 
reached (~80% for the A3243G cell used here), 
cells experience too little compensation from 
the neutral variants leading, under selective 
conditions, to their elimination from the 
population. 
Mice carrying neutral mtDNA haplotypes in a 
heteroplasmic fashion have been instrumental 
in establishing the germ line mitochondrial 
genetic bottleneck/random segregation 
hypothesis (4). Recently this hypothesis has 
been challenged by the fact that the dramatic 
reduction of the mtDNA copy number needed 
to create a genetic bottle neck that leads by 
random segregation to great variance in 
heteroplasmy (and even homoplasmy) in 
offspring, does not appear to occur in the 
mouse germ line (5). Studies with these 
neutral heteroplasmic mice have also shown 
that post-natally, tissue-specific non-random 
or directional segregation occurs (6), which 
appears to be under nuclear genetic control 
(7) and points to the existence of segregation 
controlling genes. Also a multitude of clinical 
studies with pathogenic mtDNA mutations 
indicate that directional segregation occurs 
in human post-embryonic life (8;9). It is not 
understood how diversity in mtDNA mutation 
load among different tissues, and hence how a 
wide spectrum of mtDNA disease phenotypes 
can occur with one specific mutation. Obviously, 
segregation is important in this respect, but 
mechanisms are elusive.
In absence of heteroplasmic mouse models 
for pathogenic mtDNA point mutations, 
transmitochondrial cybrids provide valuable 
sources for experimental mitotic segregation 
analysis. They are created by fusion of 
enucleated cells carrying two different 
mtDNA sequence variants with a nucleated 
cell that has no mtDNA (ρ0 cells). Mostly by 
analysis of bulk DNA of passages of cybrid 
clones carrying the A3243G pathogenic 
mutation, two patterns have been found: 
Abstract
At cytokinesis mitochondrial DNA (mtDNA) molecules are assumed to be physically partitioned 
to daughter cells in a stochastic fashion. In the presence of two mtDNA sequence variants (a 
situation referred to as heteroplasmy) continuation of this chance distribution process leads to 
random genetic segregation of the alleles. Here we present results of in vitro experiments and 
computer simulations indicating absence of A3243G mtDNA mitotic segregation. Occasionally, 
however, discrete heteroplasmy shifts or quantal segregations are observed. To explain the 
observations a metastable, heteroplasmic mtDNA segregation unit is postulated. Inherently 
this unit is thus multi-copy in mtDNA and as a rule faithfully replicating its wild type/mutant 
ratio. The nucleoid, the mitochondrial matrix DNA-protein complex that carries 8 - 10 mtDNA 
molecules, likely is the physical equivalent of the segregation/segregation suppression unit. The 
discrete heteroplasmy shifts observed may result from rearrangements leading to nucleoids of 
variable heteroplasmy, which segregate to fixation at a rate one order of magnitude more rapid 
than single mtDNAs would do. Reorganization of nucleoids may thus underlie A3243G mtDNA 
segregation in heteroplasmic cybrid cultures
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stable heteroplasmy and heteroplasmy drift 
to either wild-type or mutant. The number of 
stable A3243G clones exceeded the number of 
drifting clones by a factor of ~3. We counted 
42 stable clones against 15 drifting clones in 
three studies (10-12) (for review see Enriquez 
(13)). Of significance, stable heteroplasmy as 
measured on bulk DNA of cells in passages 
of cultured cybrid clone can be the result of 
random mitotic mtDNA segregation or from 
non-segregation. Only single cell analyses can 
reveal the cellular heteroplasmy distribution 
of a given cell population, but such studies 
are rare. In one such study, it was found that 
the distribution of single cell mutation loads 
after 30 weeks of culture of A3243G cybrid 
clones was too narrow to fit the random 
segregation model (14). It led to the concept 
of a multi-copy mtDNA segregation unit, the 
nucleoid, that is heteroplasmic itself and 
that replicates its wild type/mutant content 
faithfully. To explain changes in heteroplasmy 
e.g. in drifting cybrid clones it was proposed 
that the faithfully replicating nucleoid  may 
occasionally reorganize its wild type/mutant 
ratio, possibly under genetic control (14; 
15). Experimental evidence for reorganizing 
heteroplasmic nucleoids lying at the base of 
segregation is, however, very limited. Here we 
report experiments that are in strong support 
of the ‘metastable’ nucleoid model.
Figure 1: The rate of mitochondrial segregation as a function of the mtDNA copy number
The graphs represent computer-simulated mutation load distributions of the cells in the first outgrowth 
(passage 1), passage 16 and 30 of a founding  cell with 20% mutation load with 1000 (left ) and 5000 
(right) mtDNA molecules . When reaching  0 and 100% mutation, the cells are genetically fixed on the 
wild-type and mutant mtDNA respectively. Such cells appear more rapid in the clone with the lower 
mtDNA copy number. The average mutation level as measured on bulkDNA cells remains steady at 
the initial value since in this simulation there is no advantage or disadvantage to the mutation. The 
contributions of  mtDNA turnover to genetic drift in this situation is minor (mtDNA half life ~10 days (2)), 
because mtDNA replication is mostly driven by mitosis (~1 day).
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Material and methods
A3243G transmitochondrial 143B cybrid were 
produced by fusing skin fibroblasts from two 
maternally inherited diabetes and deafness, 
MIDD, patients (coded V and GB) and a 
mitochondrial myopathy encephalopathy lactic 
acidosis and stroke-like episodes, MELAS, 
patient (G) with 143 B ρ0 cells as described 
(16). Cybrid cloning was by limiting dilution 
or single cell flow sorting. Cybrid cells were 
grown on Dulbecco’s Modified Eagle’s medium 
containing 4.5 mg/ml glucose and 110 µg/ml 
pyruvate (DMEM) supplemented with 50 µg/ml 
uridine and 10% fetal bovine serum. After the 
first outgrowth to near-confluence (~a million 
cells) in 9 cm dishes, they were cultured with a 
10% split of cells twice a week.
The A3243G mutation load of single cells 
was determined using a PCR/RFLP method 
(referred to as PCR/RFMT) as well as by in 
situ genotyping with Padlock/Rolling Circle 
Amplification (17) in combination with image 
analysis as described by Jahangir Tafrechi et 
al. (18). Average cellular mtDNA copy numbers 
were determined on bulk DNA with the aid 
of ∆Ct method using the SybrGreen Master 
mix (Applied Biosystems, USA) for real-time 
PCR, assuming two β-globin genes per cell. 
Primers for β-globin and mtDNA as well as 
PCR conditions were as described (19).
Array-Comparative Genome Hybridization is 
described in Knijnenburg et al. (20).
Computer simulations were started with 
a single cell containing M mutant mtDNA 
molecules and W wild-type mtDNA. The 
mtDNAs in the simulation were not organized 
into any structure. The simulated cells were 
divided at random intervals, with a mean 
division period of D = 1 day. At cell division, 
the mtDNA molecules were individually 
randomly distributed to the two daughter cells. 
The mtDNA molecules were also randomly 
destroyed with a half-life of T½ =10 days (2). 
mtDNA replication was modeled by copying 
individual mtDNA molecules at a set rate R 
= ln(2) Nt [ (1/T½) + (1/D)], where Nt was the 
copy number of mtDNA in the simulated cells. 
The mtDNA molecules to be copied were chosen 
at random, with no preference to either wild-
type or mutant (3). After the simulated cell 
population has reached 1 million cells we began 
simulating cell culture passages by selecting 
100,000 cells (1/10th of the population) at 
random from the total cell population, with 
this sampling taken every 3½ days.
Results and discussion
In a first series of experiments we generated, 
by PCR-FMT (21), mutation load histograms 
of individual cells in multiple passages 
of 3 sub-cloned A3243G mtDNA 143B 
transmitochondrial cybrid founding cells 
cultured under non-selective conditions and 
performed computer simulations of random 
mitotic segregation specified to these cells 
in terms of heteroplasmy and mtDNA copy 
number. The experimental and computer 
simulation results are presented in Figure 2. 
Cells in the first outgrowth of the founding 
cell (~20 generations; passage 1) of clone 
G55_2 proved to possess mutation loads 
of ~50-55 % with a distribution that is 
substantially narrower than the simulated 
one. Cells in passage 1 of clones GB_14 and 
GB_20 had mutation loads of 70-75 % and 
90-95 % respectively, also at a much more 
narrow distribution than predicted. All 
clones maintained a narrow distribution in 
subsequent passages, whereas according to the 
simulation, homoplasmic cells should have been 
very abundant at passages > 17 for G55_2 and 
passage ≥ 5 for GB_14 and GB_20. As cellular 
mtDNA copy number values for the computer 
simulations, 500 was used for G55_2, which is 
actually above the experimentally determined 
copy number of 284 (SD=117, n=3). For G55_
2 and for GB_14 and GB_20 1500 was used, 
which is representative of the mtDNA copy 
number in 24 GB sub-clones analyzed: 1469 
(SD=544, n=24). Under a random segregation 
regime, the clones theoretically would need to 
have very much higher mtDNA copy numbers 
to explain the experimental histograms.
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Figure 2: Experimental and computer simulation single cell mutation load histograms of multiple 
passages of A3243G mtDNA heteroplasmic 143B transmitochondrial stable cybrid clones G55_2 (a,d), 
GB_14 (b,e), GB_20 (c,f) 
(a-c) Cybrids cells were cloned, expanded to a million cells (~20 generations, passage 1) and 
continuously cultured with a 10% split twice a week. At the indicated passages, single cells were sorted 
in 96-well optical plates and processed for single cell mutation load measurements by PCR-RFMT (~250 
cells per histogram). 
(d-f) For computer simulated histograms (10.000 cells per histogram) the algorithm for random 
segregation used as heteroplasmy value for the founding cell, the average mutation load found in 
passage 1:  56% for clone G55_2, 70% for GB_14 and 92% for GB_20.  As values for cellular mtDNA copy 
number, 500 was used for G55_2 and for GB_14 and GB_20 1500 was used.
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Yet we considered whether at moderate copy 
numbers, the stable heteroplasmies observed 
can still be explained by random segregation 
of mtDNAs. Theoretically negative selection 
for cells drifting towards mutant and wild-type 
mtDNA provides an explanation, but this is 
biologically highly improbable. Alternatively, 
it can be envisaged, that a delicate balance 
between negative selection of cells that drift 
to mutant and replicative advantage for 
mutant mtDNA creates a situation in which a 
population gets enriched for cells that have a 
heteroplasmy just under the threshold level. 
However, we observed stable heteroplasmy 
at 3 different levels, including one above the 
threshold level.
In view of the existence of the nucleoid with 
its multi-copy mtDNA nature, absence of 
segregation can best be explained with the 
nucleoid being a multi-copy segregation unit 
that is discretely heteroplasmic and faithfully 
replicating its wild type/mutant ratio as 
proposed by Lehtinen (14) and illustrated in 
Figure 3a.
In our cybrid repository we identified a A3243G 
cybrid sub-clone (V_50) that by gel-based PCR-
RFLP mutation load measurement on bulk 
DNA showed to be drifting from ~ 98% mutant 
to wild type over a period of a year under non-
selective culture conditions. (Figure 4, left 
panel). It provided a unique occasion to test 
the idea of a reorganizing nucleoid underlying 
segregation by analyzing its heteroplasmy 
evolution at the single cell level. Individual 
cells of the first passage analyzed were mostly 
95-100% wild type. At passage 6 the great 
majority of the individual cells was shifted 
to 90-95% heteroplasmy, following which a 
second discrete shift to ~50-55% heteroplasmy 
occurred as evidenced by the significant 
subpopulations at 50-55% heteroplasmy in 
passages 42 48 and 62. Finally, a third shift 
to homoplasmy wild type occurred (Figure 4, 
right panel). 
Figure 3: Model for the mitotic consequences of 
a genetically stable heteroplasmic segregation 
unit and of its rearrangement.
 
(a) Schematic representation of the mitotic 
consequences of random mtDNA segregation 
and a stable heteroplasmic mtDNA segregation 
unit. The hypothetical founding cell is 50% 
heteroplasmic with 72 mtDNA arranged in 9 
segregation units each with 8 mtDNAs, 4 of 
which are variant. Upon their faithful replication 
and partitioning to daughter cells for N mitosis, 
all 2N descendant cells acquire the same 50% 
heteroplasmy level. 
(b) Schematic representation of the mitotic 
consequences of a transient loss of faithful 
replication in one segregation unit of a cell from 
(a) which acquired 6 instead of 4 variant mtDNA 
molecules.  Upon random mitotic segregation of 
the units, 1/9th of the cells will become fixed at 
75% heteroplasmy and 8/9th at 50%. Reassembly 
of mtDNAs in nucleoids following a complete 
transient loss of nucleoid structure will result in 
descendant cells with heteroplasmies from 0% 
to 100% in discrete steps of 12.5% with binomially 
distributed frequencies.
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Results described thus far were obtained 
with a PCR-RFLP mutation load assay based 
on melting curve analysis (PCR-RFMT). We 
confirmed qualitatively and quantitatively 
the G55_2 results as well as the discretely 
shifted 50-55 % heteroplasmy peak in V_50 
with a different method based on direct in 
situ hybridization and ligation of A3243G 
padlock probes and target-primed rolling circle 
amplification (padlock/RCA) in combination 
with image analysis for quantitation purposes 
(17;22) as shown in Figure 5. 
We explained the heteroplasmy shifts of V_50 
in terms of the metastable nucleoid, but not 
after having considered random segregation 
in combination with selection against the 
higher mutant cells either and/or replicative 
advantage for wild type. These combinations 
intuitively explain the overall shift from near 
100% mutant to wild type. However, these 
combinations do predict gradual appearance 
of homoplasmic wild type cells only and no 
heteroplasmic peak such as the one seen at 
50-55%, making it very unlikely that random 
mitotic segregation of mtDNAs is operational 
in these cells.
For the emergence in V_50 of the 90-95% 
heteroplasmy subpopulation, we inferred that 
in the founding cell at least one faithfully 
replicating 90-95% heteroplasmic segregation 
unit (nucleoid) was present amongst 
homoplasmic mutant nucleoids and that it 
segregated randomly so that in relative low 
frequency stable heteroplasmic cells emerged 
with uniform, 90-95 % heteroplasmic, faithfully 
replicating nucleoids. Such a cell then clonally 
expanded due to growth advantage as 
witnessed by the significant sub-population in 
passage 6 at 90-95% heteroplasmy. 
With chromosome instability and presence of 
multiple karyotypically different subclones 
being a hallmark of cancer cell lines, we reasoned 
that genetic instability of the 143B nucleus 
generated, by chance, nuclear determined 
growth advantage to one or more such 90-95% 
heteroplasmy cells. Chromosome analysis by 
Combined Binary Ratio FISH (23) showed 
the cybrids to possess aberrant karyotypes 
(not shown). Although this is indicative for 
genomic instability it is no formal proof. Array 
Comparative Genomic Hybridization (array-
CGH), however, proved the nuclear genomic 
instability of the 143B nuclear genome (Fig. 
6). Thus a scenario is plausible in which the 
nuclear genomic constitution of a cell, that 
hosted uniform 90-95% heteroplasmic mtDNA 
nucleoids, provided it with growth advantage, 
effectively leading to genetic hitchhiking of the 
heteroplasmic nucleoid.
Figure 4: Bulk and single cell mutation loads of the shifting clone V_50
Heteroplasmy evolution in V_50 by bulk DNA mutation load analysis as a function of passage 
number showed apparent drift for this clone. Grey symbols correspond to the passages analyzed 
at the single cell level. Single cell analysis of selected passages of V_50 (~350 cells per histogram) 
revealed discrete shifts in cellular mutation load.
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We next reasoned that the heteroplasmy shifts 
in V_50 from 90-95% to 50-55% and then on to 
0-5% can be explained with the nucleoid if it 
occasionally makes errors in replication of its 
wild type/mutant ratio or undergoes genetic 
rearrangements, similar but not identical to 
imbalanced nuclear chromosome translocations 
(see Figure 3b). Such events will lead to altered 
wild type/mutant ratios of the nucleoids. 
In the example of Figure 3b, such newly emerged 
‘homologous’ nucleoids will segregate at a rate 
8-fold faster than single mtDNAs would and 
thus rapidly seed cells in the population with 
uniform heteroplasmic nucleoids of altered 
genetic composition, which then may hitchhike 
with cells with nuclear determined growth 
advantage, as outlined above. 
Figure 5:Quantitative and qualitative correlations between single cell A3243G mtDNA PCR-RFMT and 
Padlock/RCA results. 
(a) Relative single cell mutation load histograms generated by PCR/RFMT for G55_2 passage 17 
(n=276) and by Padlock/RCA for passage 17 + 4 (n=74). For Padlock/RCA a liquid nitrogen aliquot was 
re-grown for an additional 4 passages.
(b) Photomicrographs of cells from clone G_55 passage 17 + 4 (400x) genotyped in situ by Padlock/
RCA. Red dots correspond to mutant and green dots to wild type mtDNA.
(c) Relative single cell mutation load histograms generated by PCR/RFMT for V_50 passage 48 (n = 
342) and by Padlock/RCA for passage 48 + 4 (n= 535). The reduction in frequency of the 85-95% range 
for the Padlock/RCA likely relates to the liquid nitrogen archiving and re-growth. See also Jahangir 
Tafrechi et al. for a similar correlation for GB_20 Passage 17 (21). 
(d) Photomicrographs of cells from V_50 passage 62 + 4 (630x). Note the presence in this image of 
wild type daughter cells (arrow heads) amidst the heteroplasmic cells. Eventually these overtook the 
culture in passage 99.
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This line of reasoning (reorganization and 
subsequent segregation of heteroplasmic 
nucleoids, followed by nuclear determined 
growth advantage of a cell with altered but 
uniform heteroplasmic nucleoids) may as such 
explain the discrete shifts from mutant to wild 
type seen in V_50; it also predicts discrete 
shifts in cellular mutation loads from wild type 
to mutant. In an ongoing second similar long 
term segregation analysis initiated during this 
Thesis work with 10 subclones of passage 42 
of V_50 this was exactly what was observed. 
Clone, V3.18 by bulk DNA analysis gradually 
shifted to mutant and showed upon single 
cell padlock/RCA analysis a discrete cellular 
heteroplasmy shift from wild type to mutant 
(see Chapter 6 for Figure). Furthermore in 
support of the ‘stable’ element of the metastable 
nucleoid model, another subclone with ~ 
1800 mtDNAs proved to be stable at  ~ 65% 
heteroplasmy up to passage 81 (see Chapter 6, 
page 81 for Figure). 
Mitochondrial nucleoids are nucleo-protein 
complexes located in the matrix of the 
mitochondrial compartment. They physically 
are associated with multiple mtDNAs. 
Molecular cytological studies indicated that 
the average number of mtDNA per nucleoid 
varies per cell type, but that it is in the range 
of 2-10, with ~8 for the 143B host cell line used 
here (24;25). This approximate one order of 
magnitude difference between mtDNA and 
nucleoid copy number is compatible with our 
results. Thus the nucleoid, as a metastable 
segregation unit with multiple mtDNAs, 
likely mediates the segregation suppression 
and quantal segregation observed here. More 
similar, long term segregation studies will be 
needed, however, to arrive at the exact quantal 
number, to document cell type dependence 
and to answer the question whether or not the 
metastable nucleoid model holds for neutral 
and other pathogenic mtDNA mutations.
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Figure 6: Chromosome instability of the 143B nuclear genome assessed by Array-Comparative 
Genome Hybridization with ~ 1 Mbp resolution of genomic DNA from V_50 passage 6 as test-DNA and 
V_50 passage 62 as reference-DNA.
Red, blue and green dots represent respectively, copy number change, no copy number change 
and natural copy number polymorphisms. Thresholds for gains and losses were set at a 2log change of 
± 0.33 (y-axis) and all data were sorted according to chromosome number (x-axis). 
These results indicate the changes which did occur during 28 weeks of culturing.
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Abstract
The pathobiochemical pathways determining the wide variability in phenotypic expression of 
mitochondrial DNA (mtDNA) mutations are not well understood. Most pathogenic mtDNA mu-
tations induce a general defect in mitochondrial respiration and thereby ATP synthesis. Yet phe-
notypic expression of the different mtDNA mutations shows large variations that are difficult 
to reconcile with ATP depletion as sole pathogenic factor, implying that additional mechanisms 
contribute to the phenotype. Here we use DNA micro-arrays to identify changes in nuclear gene 
expression resulting from the presence of the A3243G diabetogenic mutation and from a deple-
tion of mtDNA (ρ0 cells). We find that cells respond mildly to these mitochondrial states with 
both general and specific changes in nuclear gene expression. This observation indicates that 
cells can sense the status of mtDNA. A number of genes show divergence in expression in ρ0 
cells compared to cells with the A3243G mutation, such as genes involved in oxidative phospho-
rylation. As a common response in A3243G and ρ0 cells, mRNA levels for extracellular matrix 
genes are up-regulated, while the mRNA levels of genes involved in ubiquitin-mediated protein 
degradation and in ribosomal protein synthesis is down-regulated. This reduced expression is 
reflected at the level of cytosolic protein synthesis in both A3243G and ρ0 cells.
Our finding that mitochondrial dysfunction caused by different mutations affects nuclear gene 
expression in partially distinct ways, suggests that multiple pathways link mitochondrial func-
tion to nuclear gene expression and contribute to the development of the different phenotypes in 
mitochondrial disease.
Key words: mitochondria, mtDNA, expression, diabetes
mitochondria is expected to give insight in 
the pathobiochemical pathways affected in 
mitochondrial disease (4;5).
In order to investigate how mitochondrial 
mutations affect the nuclear gene expression 
profile we created 143B cybrid cells with 
mitochondrial DNA being the only variable 
(6). The first state of respiratory dysfunction 
is induced by an A to G conversion at location 
3243 in the tRNAleu gene of the mitochondrial 
DNA. This mutation causes Maternally 
Inherited Diabetes and Deafness (MIDD) (7) 
in most carriers and associates also with the 
neuromuscular MELAS syndrome (8). Another 
state of mitochondrial dysfunction is induced 
by a depletion of mtDNA (ρ0 cells). Using 
cybrid cells with 100% wild-type mitochondrial 
DNA, cybrid cells with 100% A3243G mutant 
mitochondrial DNA of the same haplotype and 
ρ0 cells, we found both common mitochondrial-
defect and MIDD specific responses in nuclear 
gene expression.
Introduction
Mitochondrial dysfunction caused by 
mutations in the mitochondrial genome is 
related to a variety of diseases such as type 
two diabetes mellitus (DM2), cancer and 
neuro-muscular diseases (1). Mitochondria are 
involved in multiple cellular processes of which 
ATP production by oxidative phosphorylation 
(OXPHOS) is the most prominent one. 
However, mitochondria also accommodate 
other processes such as the tricarboxylic acid 
cycle and fatty acid oxidation. In addition, 
mitochondrial function is linked to calcium, 
iron and ROS signalling and apoptotic 
pathways. The variation in clinical phenotype 
of mitochondrial diseases is difficult to explain 
by merely a reduced respiration rate (2). Rather 
the consequences of additional mitochondrial 
dysfunction on retrograde signalling pathways 
may determine the distinct nature of the 
clinical manifestation (3). A genome-wide 
differential gene transcription profile of 
normal cells and cells with dysfunctioning 
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Materials and methods
Cell culture, cell characteristics and Gene-
Chip hybridization
The cybrid cells used in this report have 
been previously described (2;9). In short, 
143B osteosarcoma cells were treated with 
ethidium bromide to create ρ0 cells devoid of 
mitochondrial DNA. Next, ρ0 cells were fused 
with enucleated cells from a MIDD patient, 
generating clones with different but stable 
heteroplasmy levels for the 3243 mutation. 
Two apparently homoplasmic mutant (VM48 
and VM50) and two apparently homoplasmic 
wild-type (VW6 and VW7) cybrid clones were 
selected and used as biological replicates in 
this study. The cells were grown on Dulbecco’s 
Modified Eagle’s medium containing 4.5 mg/
ml glucose and 110 g/ml pyruvate (DMEM) 
supplemented with 50 g/ml uridine and 10% 
fetal bovine serum. Heteroplasmy levels were 
monitored by use of PCR-RFLP and ApaI, 
which cleaves the mutated PCR product. 
The oxygen consumption of the cells was 
measured as described previously (6). 
Mitochondrial copy numbers were determined 
by comparing the amount of mitochondrial 
DNA with the amount of -globin DNA, in a 
SybrGreen Real Time PCR reaction with the 
primers described in Szuhai et al. (10) and 
using the ABi Prism 7700 spectrofluormetric 
thermal cycler (Applied Biosystems, USA). 
The same system was used for validation 
of the mRNA concentration data obtained 
by chip hybridisation analysis. Primer sets 
for ten different genes were used, including 
three that were found to be differentially and 
consistently expressed: 
NADH dehydrogenase 18 (5’ACGAACCT-
TACCCGGATGATG + 5’CATGGATCTCTCT-
CATGCTGTGAG), ubiquitin-conjugating 
enzyme E2D3 (5’ATCACAGTGGTCGCCT-
GCTT + 5’ATAGATCCGTGCAATCTCTGGC) 
and collagen VI2 (5’CATCGATGACATGGAG-
GACGT + 5’CAGCTCTGTTTGGCAGGGAA). 
The primers were all manufactured by 
Eurogentec, Belgium.
Cytoplasmic protein synthesis rate was 
estimated from the incorporation of L-[4,5-3H]-
leucine into trichloroacetic acid precipitable 
material essentially as described (2). In brief, 
series of cells at different densities in 6-well 
plates were washed with phosphate-buffered 
saline and incubated for 60 min. at 37° C 
in 0.75 ml of leucine-free complete medium 
containing 10 mCi of L-[4,5-3H]-leucine and 10 
mM unlabelled leucine. Cells were then again 
washed three times with phosphate-buffered 
saline and thoroughly dissolved in 1 ml 0.2 
M NaOH. 100 ml aliquots were precipitated 
by the addition of 100 ml 20 % trichloroacetic 
acid, and assayed for total protein content by a 
bicinchoninic acid based protein assay (Pierce, 
USA) and for the incorporation of [3H]-leucine 
into protein using a GF/C filter assay. The 
rate of protein synthesis is expressed as the 
amount of [3H]-leucine incorporated into 1 μg 
protein during the 1-hour incubation period 
(cpm.mg-1.h-1). Protein concentration was also 
used as an estimate for cell density. 
Biotinylated cRNA samples were prepared 
according to the Affymetrix GeneChip 
protocol. In short, cells at 90% confluency 
were washed with phosphate buffered saline 
and directly lysed in RNA-Bee solution (Tel-
Test, USA). RNA purification was performed 
with the RNeasy mini kit (Qiagen, Germany). 
With the intensity-ratio of the 28S/18S rRNA 
bands being over 1.8, the integrity of the RNA 
was confirmed. 20 mg of total RNA was used 
to perform double-stranded cDNA synthesis 
with an oligo T7-dT24 primer and SuperScript 
kit (Invitrogen Life Technologies, USA). The 
cDNA was purified with Phase Lock Gel-
reaction tubes (Eppendorf, Germany) and the 
complete pellet was used for a simultaneous 
6-hour in vitro transcription and labeling 
reaction using the MegaScript T7 kit 
(Ambion, USA) and biotin-11-CTP/biotin-
16-UTP (PerkinElmer Life Sciences, USA). 
Finally, 20 mg fragmented cRNA was used for 
hybridization on Affymetrix HG-U133 chips, 
according to the manufacturer’s instruction. 
Affymetrix’ Microarray Suite 5.0 Software 
(MAS) was used to determine the percentage 
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of transcripts Present and the 3’/5’ intensity 
ratios for b-actin and GAPDH.
Probe Level Analysis (PLA) and Gene Set 
Enrichment Analysis (GSEA)
Most data analyses were performed in R (www.
r-project.org) using the Bioconductor functions 
(www.bioconductor.org). Intensity data was 
corrected for background arising from optical 
noise as well as from non-specific hybridisation, 
according to the procedure developed by Wu et 
al. (11) and annotations were added using the 
annotation package hgu133a, version 1.3.1 
(12). The arrays were normalized using the 
VSN-transformation (13). 
To determine differential expression of the 
genes on the array, the pre-processed data were 
handled using the algorithms described in Liu 
et al. (14) which makes use of the feature that 
each transcript is represented by eleven 25-
mer perfect-match probes. The scripts for data 
processing are available at www.medgencentre.
nl/pla. In short, the eleven probe-intensities of 
each transcript from a reference hybridisation 
(VW6 or VW7) were compared to the eleven 
probe-intensities of the corresponding 
transcript from a test-hybridisation (VM48, 
VM50, ρ0_1 or ρ0_2) using paired Wilcoxon 
statistics (15) to calculate a one-tailed p-value. 
The signals from the mismatch probes were 
not subtracted. A perturbation factor was set 
at 1.1 to exclude transcripts with very small 
changes in their intensity levels (14). The most 
conservative one-tailed p-value (the one closest 
to 0.5) was assigned as the change-value. If 
the p-values after perturbation are on opposite 
sides of 0.5, the transcript will be classified as 
‘not changed’ and it will be assigned a change-
value of 0.5. 
For all transcripts in pair-wise comparisons 
the test will assign a change-value between 0 
and 1. A change-value of 0 indicates that all 
probe-intensities of a test-transcript are higher 
than the corresponding probe-intensities of 
the reference-transcript. Conversely, a change-
value of 1 corresponds to an overall decrease. 
All change-values between these two extremes 
indicate a partial or complete overlap of 
the probe intensity-patterns. When there 
is a totally random pattern (at noise-level 
intensity) the change-value will be 0.5 and the 
corresponding transcript is considered as not 
changed in mRNA concentration. 
Subtle changes are considered to be of biological 
relevance if the change is consistent within 
a gene set. Therefore, as a second approach, 
Gene Set Enrichment Analysis (GSEA) was 
performed on all 22,283 transcripts to pinpoint 
the most coherently changed gene sets per 
comparison (16). Gene sets were derived 
from the Kyoto Encyclopaedia of Genes and 
Genomes (KEGG) and from the Gene Ontology 
consortium (GO). Expression changes were 
calculated with Signal to Noise Ratio’s. 
Fig. 1. Frequency histogram of the PLA change-
values.
This histogram depicts the amount of transcripts 
with a change in expression level between 3243 
mutant clone VM48 and wild type clone VW6. 
Values between 0 and 0.5 indicate an increase, 
values between 0.5 and 1 a decrease. 
A pertubation factor of 1.1 has been used.
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Results
Cell characteristics and quality controls
The cybrid cell lines selected for gene 
expression profiling were comparable to each 
other with respect to cell morphology, doubling 
time (range 13h - 18h) and cell viability (~ 4% 
trypan blue stained cells). The average oxygen 
consumption of the wild-type cybrids was 1.3 
±0.3 fmol/min/cell (n = 10), while this value for 
the 100% 3243 mutant cybrids was 0.1 ±0.1 
fmol/min/cell (n = 5). ρ0 cells did not respire 
at all. Mitochondrial copy numbers of the 
wild type and the 3243 mutant cybrids were 
comparable (Real Time PCR data not shown).
For mRNA expression profiling the cells were 
grown under standardized conditions to ~90% 
confluence. Quality control was performed at 
each step of RNA isolation and cRNA synthesis 
and no variations were detected in yields and 
length distribution of the products. Before 
starting PLA and GSEA analysis we demanded 
that the fraction of detectable or ‘present’ genes 
and the 3’/5’ hybridisation ratio fell within 
Affymetrix’ boundaries (< 10% variation and 
< 3 respectively). For the 6 hybridisations, the 
mean percentage ‘present’ transcripts was 47.5 
±0.9% and the 3’/5’ ratios were 1.2 ±0.09 for 
actin and 0.9 ±0.04 for GAPDH. Quantitative 
RT-PCR data for 10 different mRNAs 
correlated very well qualitatively and to large 
extent quantitatively with chip hybridisation 
and PLA data (not shown), which is in accord 
with recent literature comparing different 
gene expression platforms (17;18).
Probe Level Analysis
An intensity frequency histogram was 
generated using all the transcripts from all 6 
hybridisations after correction for optical noise 
and non-specific hybridisation. Based on this 
histogram the threshold for minimal intensity 
was set to 25. 30% of the 22,283 transcript 
represented on the HG-U133A micro-array 
was expressed above threshold in at least one 
cell type. The average expression of these 6691 
transcripts was 516.
The frequency histogram of the PLA change-
values in the comparison VM48 versus 
VW6 is shown in figure 1 as an example. It 
illustrates that the majority of transcript 
are not changed in expression and that most 
of the remaining transcripts have a change-
value of 0 or 1. For a given transcript to be 
included in the list of differentially expressed 
transcripts, we demanded that all four 
change-values associated with it are either 
all > 0.5 (decreased) or all < 0.5 (increased). 
With this criterion, 553 of the 6691 transcripts 
(8%) were considered differentially expressed 
when comparing the 3243 mutant to wild type 
cells. The number of differentially expressed 
transcripts in the comparison between ρ0 
cells and wild type cells was more than 3-fold 
higher (28%). Notably, in the comparison of 
ρ0 and 3243 mutant 1581 transcripts (24%) 
were found to be changed (Table 1). The 553 
transcripts found in the 3243 mutant versus 
wild type comparison do not constitute a full 
subset of the 1869 transcripts of the ρ0 versus 
wild type comparison. The single-nucleotide 
A3243G substitution and the absence of mt-
DNA apparently reschedule the nuclear gene 
expression in different ways. 
Table1. Number of transcripts changed in two-way comparisons 
Two-way 
comparison
# Changed 
Transcripts
Relative amount # Down- 
regulated
# Up-regulated
3243_Wt 553 8,3 % 295 258
r0_Wt 1869 27,9 % 719 1150
r0_3243 1581 23,6 % 1031 550
The transcripts changed in the 3243 versus wild type comparison is not a complete subset of any other 
comparison
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A three-way cell type comparison technique 
was used to identify the transcripts that behave 
similarly in the two types of dysfunctioning 
cells (A3243G and ρ0) as well as the transcripts 
that behave distinctively. Note that in this 
comparison with duplicate hybridisation 
experiments, eight change-values are to be 
considered: 2 A3243G cell clones versus 2 
wild type cell clones and 2 times ρ0 versus 
the 2 wild type cell clones. As a result the 
stringency for inclusion of transcripts in the 
lists of differentially expressed transcripts 
is further increased, because for generation 
of the ‘common change’ list it was demanded 
that all eight (2 x 4) change-values indicate 
a change in the same direction. Similar, to 
generate the ‘specific’ lists, it was demanded 
that none of the four corresponding change-
values of the other mutant versus wild type 
comparison indicate a change in the same 
direction. All transcripts that did not exactly 
meet one of these two criteria were rejected. 
The results are presented as a Venn diagram 
in figure 2, which shows that 229 transcripts 
have a similar change of expression in both 
mitochondrial mutant cell lines. Interestingly, 
155 transcripts are changed specifically in ρ0 
cells whereas 73 additional transcripts are 
specifically altered in 3243 mutant cells. 
The relative changes in gene expression due 
to mtDNA mutations appear to be rather mild 
with maximal differences of ~5-fold and no 
on/off situations. The transcripts with a 2-fold 
change in any of the three cell-type comparisons 
are listed in Table 2. The quantitative RT-
PCR data of three differentially expressed 
genes are included. Tables 4 through 9 in the 
supplementary material contain the PLA data 
of all 457 differentially expressed transcripts.
 
Gene Set Enrichment Analysis
In contrast to PLA, which analyses differences 
in expression of individual transcripts, Gene 
Set Enrichment Analysis (GSEA) pinpoints 
sets of genes that are coherently changed 
in their expression. When using the Kyoto 
Encyclopaedia of Genes and Genomes (KEGG) 
and the Gene Ontology consortium (GO) data 
bases as predefined input gene sets, GSEA 
calculates for each cell type comparison 
an enrichment score for all gene sets (16), 
ranging from 0 to well over 300. Both KEGG 
and the GO consortium provide a controlled 
vocabulary to describe gene products, which 
are grouped together according to process, 
pathway or localization. In the case of KEGG, 
the transcripts on the HG-U133A chip are 
divided into 107 pathway-specific gene sets. 
The GO consortium on the other hand, makes 
use of three different classifications according 
to Biological Process (GO-BP), Cellular 
Component (GO-CC) and Molecular Function 
(GO-MF). GO-CC divides the transcripts into 
356, GO-BP into 1317 and GO-MF into 1461 
gene sets. For all of these predefined gene sets, 
enrichment scores were calculated for all three 
comparisons (supplementary material table 
10). Gene sets with an ES above a threshold 
of 300 may be considered as biologically 
significant since they represent 2.5% of all 3241 
gene sets. Representative gene sets of these 82 
gene sets are depicted in Table 3. Three types 
of effect may be distinguished: mutant-specific 
effects, effects common to both ρ0 and A3243G 
and opposite effects.
Fig. 2. Three-way comparison
This Venn diagram shows the number of 
transcripts that are changed in common and 
specifically when compared to wild type cybrids 
cells. 
The three groups shown in this figure correspond 
to the 6 supplemented lists, where the up- and 
down-regulated transcripts are presented 
separately.
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Table 2. Transcripts changed more than two fold. 
Affy-code R/W M/W R/M Description
Opposite effect
39729_at 2,16 0,44 4,86  peroxiredoxin 2
200734_s_at 2,89 0,93 3,12  ADP-ribosylation factor 3
218275_at 2,04 0,90 2,27  solute carrier family 25 (mit, carrier; dicarboxy-
late transporter), member 10 
213421_x_at 2,00 0,99 2,01  protease, serine, 3 (mesotrypsin)*
201227_s_at 1,93 (1.99) 0,92 (0.98) 2,10 (2.23)  NADH dehydrogenase (ubiquinone) 1 beta 
subcomplex, 8, 19kDa
 
207076_s_at 1,53 5,27 0,29  argininosuccinate synthetase
213506_at 0,73 2,07 0,35  chaperonin containing TCP1, subunit 3 
(gamma)*
201012_at 0,48 1,49 0,32  annexin A1
208944_at 0,49 1,46 0,34  transforming growth factor, beta receptor II 
(70/80kDa)†
44783_s_at 0,33 1,39 0,24  hairy/enhancer-of-split related with YRPW 
motif 1
202006_at 0,44 1,13 0,38  protein tyrosine phosphatase, non-receptor 
type 12
Common effect
209156_s_at 4,50 (1.50) 4,08 (1.47) 1,09 (1.02)  collagen, type VI, alpha 2†
201438_at 3,01 3,68 0,81  collagen, type VI, alpha 3†
213905_x_at 2,91 2,48 1,17  biglycan†
201673_s_at 2,77 2,39 1,16  glycogen synthase 1 (muscle)
220642_x_at 2,53 2,27 1,12  putative G-protein coupled receptor
211964_at 3,10 2,20 1,41  collagen, type IV, alpha 2†
200815_s_at 2,38 2,03 1,17  platelet-activating factor acetylhydrolase, 
isoform Ib, alpha subunit 45kDa
212048_s_at 2,27 1,87 1,21  tyrosyl-tRNA synthetase
200623_s_at 2,31 1,71 1,36  calmodulin 3 (phosphorylase kinase, delta)
203137_at 0,50 0,45 1,10  Wilms tumor 1 associated protein
203008_x_at 0,44 0,53 0,84  ATP binding protein associated with cell dif-
ferentiation
209137_s_at 0,50 0,69 0,72  ubiquitin specific protease 10*
200667_at 0,40 (0.58) 0,60 (0.62) 0,66 (0.94)  ubiquitin-conjugating enzyme E2D 3 (UBC4/5 
homolog, yeast)*
203432_at 0,50 0,77 0,66  thymopoietin
201901_s_at 0,46 0,79 0,58  YY1 transcription factor
W = 100% wild type cybrid cells, M = 100% A3243G mutant and R = depletion of mtDNA.
Data in brackets is calculated from real time pcr data.
*Transcripts associated with ubiquitinylation.
†Transcripts associated with extracellular matrix formation.
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Correlation of GSEA and PLA
Both the PLA and GSEA techniques indicate 
moderate but significant effects of mtDNA 
mutations on the nuclear expression profile of 
osteosarcoma cells. Because it is reasonable to 
assume that relatively mild effects of mtDNA 
mutations on nuclear gene expression are of 
biological interest, we have chosen to focus on 
coherently changed gene sets using the GSEA 
method and to use PLA as confirmation.
The KEGG gene set ‘ribosome’ was found 
down-regulated in both the 3243 mutant (ES 
= 360) and in ρ0 cells (ES = 306). The three 
corresponding GO groups gave similar results. 
The average effect on ribosomal protein gene 
expression was small (< 10%) but consistent 
(p < 0,01), and always found more strongly 
down-regulated in 3243 mutant cells than in 
ρ0 cells. 
The mRNA expression of both the mitochondrial 
and the cytoplasmic ribosomal proteins was 
affected, but the expression of cytoplasmic 
protein genes for the small ribosomal subunit 
40S (GO:0005843) seems to be affected most 
(Figure 3A). To analyse whether this small 
reduction in expression of cytosolic ribosomal 
protein genes has any biological consequence we 
measured the rate of cytosolic protein synthesis 
as reflected by [3H]-leucine incorporation in 
these cell lines. Both the A3243G and ρ0 cells 
do indeed show an unambiguous reduction in 
protein synthesis rate compared to the wild 
type cell lines as shown in figure 3B.
The proteins involved in ubiquitin-mediated 
proteolysis were also found coherently down-
regulated in both mutant cells. Within the 
KEGG data base one can find the ‘ubiquitin 
Table 3. Enrichments scores for biological clustering groups.
GSEA 3243_wt (ES)* r0_wt r0_3243
Common effect
MF: ubiquitin-protein ligase activity† 316 i 321 i 217 i
MF: RNA binding activity 533 i 583 i 196 i
KEGG: ribosome† 360 i 306 i h 260
CC: collagen h 231 h 353 h 121
A3243G specific
MF: actin binding activity h 428 h 173 255 i
MF: Ca2+ binding activity h 333 h 138 157 i
CC: basement membrane h 327 h 135 192 i
KEGG: alanine and aspartate metabolism h 326 h 199 138 i
r0 specific
BP: amino acid transport h 195 h 326 h 302
CC: nuclear pore 227 i 535 i 500 i
BP: mitosis 202 i 367 i 321 i
Opposite effect
CC: mitochondrion† 271 i h 341 h 584
KEGG: ubiquinon biosynthesis 215 i h 237 h 310
BP: TGF-b receptor signaling pathway h 142 191 i 322 i
*The threshold for the enrichment score (ES) is set at 300. The arrows indicate either a global decrease 
or increase of the transcripts in the cluster.
†The three criteria ‘ubiquitin-protein ligase activity’, ‘ribosome’ and ‘mitochondrion’ have similar results 
for comparable criteria in all of the other groups. 
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mediated proteolysis’ gene set. However in the 
GO data base, these genes are found rather 
scattered throughout the gene sets: Within 
GO-MF four different gene sets with ubiquitin-
related proteins can be recognized; ‘ubiquitin-
protein ligase activity’, ‘ubiquitin C-terminal 
hydrolase activity’, ‘ubiquitin-specific protease 
activity’ and ‘ubiquitin conjugating enzyme 
activity’. Within GO-BP there are two gene 
sets present: ‘ubiquitin cycle’ and ‘ubiquitin-
dependent protein catabolism’. All these gene 
sets have an ES > 300 for down-regulation in 
ρ0 and an ES ~300 for down-regulation in 3243 
cells. In line with this, two transcripts involved 
in ubiquitin mediated proteolysis were found > 
2-fold down-regulated according to PLA (Table 
2).
The extracellular matrix proteins were found 
to be up-regulated in both mutant cell lines. 
In the GO-CC data base the group ‘collagen’ 
clearly emerged for the ρ0 cells and to a lesser 
extent also for the 3243 mutant cell. This 
result was confirmed by PLA, where three 
different collagens as well as the pericellular 
matrix protein biglycan can be found strongly 
up-regulated, this time with the 3243 mutant 
showing a much larger effect compared to the 
ρ0 cells (Table 2).
The KEGG defined gene set ‘oxidative 
phosphorylation’ was found specifically up-
regulated in ρ0 cells (ES = 384). The enrichment 
score for the oxidative phosphorylation genes 
is even larger (ES = 424) in the ρ0 versus 3243 
comparison. Comparable enrichment scores 
were found for GO-MF ‘NADH dehydrogenase 
activity’, GO-CC ‘mitochondrion’ and GO-
BP ‘oxidative phosphorylation, NADH to 
ubiquinone’.
Discussion
With the aim to elucidate pathways involved 
in mitochondrial-nuclear genome cross-talk, 
we have undertaken a genome-wide analysis 
of the alterations in nuclear gene expression 
in response to two different types of mtDNA 
mutations that both provoke mitochondrial 
dysfunction such as loss of mtDNA encoded 
Fig. 3. A: Comparison of the average mRNA levels of all 47 proteins of the cytoplasmic small ribosomal 
subunit
*The change is highly significant for both r0 and 3243 mutant according to a standard paired t-test 
(p=3x10-3 and 3x10-8 respectively).
B: Cytoplasmic protein synthesis is lower in both mutant cell lines
Because protein synthesis slows down when cells reach confluence (2), its rate is shown as a function 
of cell density, which is expressed as the amount of protein per cm2 substratum.
For gene expression profiling, cells were harvested at a density of ~40 g protein/cm2.
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proteins and respiration (8;19). The 
transmitochondrial fusion technique developed 
by Attardi and co-workers (6) permitted 
the generation of cybrid cell lines with the 
mtDNA genome being the only variable, thus 
excluding variations due to mtDNA haplotype 
and nuclear background (20). Depletion of 
mtDNA or introduction of MIDD-derived 
A3243G mtDNA in 143B osteosarcoma cells 
led to failure of the cells to respire. As a control 
we used cells containing wild type mtDNA 
derived from the same MIDD patient.
Relative mRNA abundances were measured 
using Affymetrix GeneChip technology on two 
independently grown clones of each cell type. 
With a novel Probe Level Analysis technique 
we distinguished changes in the expression 
of individual genes that are common to the 
two types of mutation as well as mutation-
specific ones (Table 2). Overall, the magnitude 
of changes in expression was moderate; only a 
handful genes reached ~ 4-fold changes. The 
genes and associated pathways identified by 
Probe Level Analysis overlapped considerably 
with those found independently by Gene Set 
Enrichment Analysis, which is well suited for 
identifying consistent changes in gene sets 
involved in given pathways (16). Our main 
conclusion therefore is that the mutational mt-
DNA status is sensed by the nuclear genome 
and reacted upon in a common and a mutation 
specific way.
The common responses likely originate from 
a failure of oxidative phosphorylation. They 
include down-regulation of ribosomal protein 
genes and up-regulation of extracellular matrix 
genes, the latter also observed in respiration-
deficient cybrids containing dimer mtDNA 
(4). The presence of the A3243G mutation 
and the absence of mtDNA also seem to 
induce mutation-specific signals towards the 
nuclear genome. A similar view has emerged 
from studies in yeast (21) where different 
respiratory chain inhibitors and the absence of 
mtDNA also induced different transcriptional 
responses. Taken together, it is conceivable that 
nuclear transcription is reprogrammed by the 
mitochondrial DNA status through different 
sensing mechanisms, similar to retrograde 
signalling in yeast (3). On its turn, mtDNA 
replication and transcription is stimulated by 
the nuclear co-activator PGC-1, the nuclear 
respiratory factors, the general transcription 
factor Sp1 and mitochondrial transcription 
factor TFAM (22;23), emphasizing the mutual 
dependence and interplay between both 
genomes.
We were intrigued by the small but consistent 
change in expression of the ribosomal proteins. 
Therefore we conducted an experiment to 
confirm these data on protein synthesis 
activity. Indeed the protein synthesis rate, 
in both the A3243G mutant and the ρ0 cells, 
is significantly lower compared to wild type 
cells. The view emerges that cells with 
defective energy supply down regulates energy 
demanding processes like protein synthesis 
(24). In accordance, genes involved in protein 
breakdown are also down-regulated, possibly 
in an attempt to compensate for the danger of 
an unbalance in protein metabolism. A study 
in yeast recently revealed that the abundance 
of ribosome biogenesis factors, which are 
more often co-ordinately down-regulated, is 
controlled at the level of mRNA stability (25). 
Since insulin production is highly depending 
on ribosome activity, it is tempting to speculate 
that a decreased rate of protein synthesis 
in the pancreatic β-cell might contribute to 
the pathogenesis of the diabetic phenotype. 
Notwithstanding the limitations of a model 
system like cultured osteosarcoma cells for 
the diabetic phenotype, it is remarkable that 
mitochondrial dysfunction often associates 
with diabetes and at least in the case of the 
A3243G mutation this is due to a reduction 
in insulin secretion capacity of the pancreatic 
beta cell (26). Mitochondrial dysfunction is 
strongly linked with development of diabetes 
type 2 (27;28). Expression studies with muscle 
tissue from diabetic humans (16;29) and 
mice (30;31) show mild down-regulation of 
nuclear OXPHOS genes, likely a consequence 
of hyperglycemia. In contrast, expression 
studies with muscle tissue and fibroblast cells 
from mitochondrial disease patients show 
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an increased expression of nuclear OXPHOS 
genes (32;33). As such, up-regulation may 
be considered a compensatory effect for the 
mitochondrial dysfunction. Accordingly, we 
found an up-regulation in OXPHOS genes 
in the mtDNA depleted ρ0 cell line, but no 
significant effect of OXPHOS gene expression 
was seen in the cells with the diabetogenic 
A3243G mutation. Taken together these 
observations, indicate the existence of at least 
two different mechanisms for OXPHOS gene 
regulation.
In conclusion, our data clearly demonstrate 
the presence of both general and specific 
communication routes between the mtDNA 
and the nuclear genomes and may contribute 
to the identification of pathways determining 
the specificity of mitochondrial diseases.
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Summary
To explain the variation in clinical phenotype of mitochondrial diseases caused by point mutations 
in mtDNA such as the A3243G tRNALeu(UUR) mutation, it has been proposed that signaling 
pathways from mitochondria to the nucleus (the retrograde response) leads to tissue and cell 
type specific responses. To identify such responses we extensively compared nuclear expression 
profiles of cell clones proficient and deficient in mitochondrial respiration because of A3243G 
mtDNA mutation. The cell clones had in principle identical nuclear background and, next to 
variation in mutation load, two different haplogroups well represented. Thus the system is well 
suited to see effects of mtDNA sequence variants on nuclear expression profiles. The results 
led us to conclude that the number of genes changed ≥1.5-fold in expression is minimal when 
comparing respiration pro- and deficient cells and no relevant genes, let alone pathways, were 
identified. Many differentially expressed genes were, however,  found when the two haplogroups 
were compared. The fact that differences in expression exist between two haplogroups may 
indicate that the mtDNA haplotype can modulate phenotypic expression, but it will be difficult 
to unravel its contribution in view of the general nature of the gene sets differentially affected 
by the haplotypes. As in the previous Chapter, we found that 100% mutant cells reduce global 
cytosolic translation rates 2-4 times. Preliminary experiments and ongoing research indicate 
the involvement of the elongation factor EF-2 and its upstream regulator AMP Kinase, while 
mTOR down regulation seems not involved in this translation repression. This highlights the 
importance of translational control in response to loss of mitochondrial respiratory function.
Introduction
Mitochondrial DNA (mtDNA) is a small, 
multi-copy, circular extra-nuclear genome 
of 16.569 base pairs, which in mammals is 
maternally inherited and thought to segregate 
randomly. Compared to the nuclear genome, 
it is more vulnerable to mutations. The lack 
of an efficient mtDNA repair mechanism and 
the location near the oxygen radical producing 
respiratory chain are considered to be the main 
reason for the high mutation rate of mtDNA. A 
cell may contain hundreds to thousands copies 
of mtDNA and a mutated form can co-exist 
with the original sequence. The occurrence of 
both wild type and mutated mtDNA is called 
heteroplasmy as opposed to homoplasmy. 
Homoplasmy is the preferred state in oocytes, 
but heteroplasmy does occur in the germ 
line, with wide variation in mutation load, 
as testified by patients with mtDNA disease.
From studies with (neutral) heteroplasmic 
mouse models, it has been inferred that during 
early oogenesis a reduction of the number of 
mtDNA molecules (the mitochondrial genetic 
bottleneck) and their random segregation, 
creates great variation in mutation load of 
the primary oocytes and hence offspring (1). 
As a consequence of the small number of 
segregating mtDNA molecules in the maternal 
germ line, return to homoplasmy in offspring 
is established by random segregation in 
relatively few and even one generation. This 
rapid genetic drift to fixation is considered key 
to purging the population from deleterious 
variants by negative selection, while positive 
selection during many generations may lead 
to the best adapted homoplasmic sequence 
variant for a given (climatic) environment. 
Characteristic demographic distribution 
of neutral mtDNA sequence variants is 
also thought to result from this rapid drift.
The human population indeed harbors a high 
level of population-specific mtDNA sequence 
variants, which are especially abundant in the 
only non-coding part of the mtDNA, the ~1000 
basepair D-loop. By means of D-loop sequencing 
and RLFP analysis a single mtDNA tree can 
be drawn originating in Africa approximately 
150.000 years ago (2). The West Eurasian 
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population can be divided in 11 haplogroups, at 
least 20 subgroups and numerous haplotypes 
(3). These haplotype mutations are present 
in all mtDNA molecules of an individual, 
in contrast to the heteroplasmic occurrence 
of most pathogenic mtDNA mutations. 
Pathogenic point mutations in mtDNA are 
remarkable in that a single specific mutation 
can cause variable disease phenotypes, whereas 
a much more common expression of disease is 
expected considering that in the end they all 
cause failure of oxidative phosphorylation. 
A relevant example of a variably expressing, 
pathogenic mtDNA mutation is the A to G 
transition at location 3243 in the tRNAleu(UUR) 
gene, which causes Maternally Inherited 
Diabetes and Deafness (MIDD) in most 
carriers (4), but also associates with the 
neuromuscular syndrome characterized as 
mitochondrial encephalomyopathy, lactic 
acidosis and stroke-like episodes (MELAS) 
(5), in which it was originally discovered. 
Also disease expressions like Alport-like 
kidney failure and Chronic Progressive 
External Ophthalmoplegia are found to 
be associated with the A3243G mutation.
Several hypotheses have been brought forward 
to explain the variation in clinical phenotype 
of mitochondrial DNA diseases. One is based 
on tissue-variation in heteroplasmy levels, 
resulting from enigmatic segregation patterns. 
Another is based on tissue and cell type specific 
effects of mitochondrial dysfunction,  affecting 
signalling pathways from mitochondria to 
the nucleus (the retrograde response) (6). 
It has also been suggested that mtDNA 
haplotype modulates disease expression. In 
the previous chapter we demonstrated, in a 
particular mtDNA haplotype, effects of the 
homoplasmic A3243G mutation on the nuclear 
gene expression profile. Here we considered 
whether the effects were specific to the A3243G-
induced respiratory dysfunction or influenced 
by the mtDNA haplotype. For this purpose 
we created additional A3243G cybrids, both 
respiratory proficient and respiratory deficient, 
with a different mtDNA haplogroup (7).
Materials and Methods
Patients
The clinical manifestations and family history 
for patients V and A have been described 
previously. Patient V was a 56 year old male 
with MIDD, with an age-of-onset of 36 and a 
heteroplasmy level of 4% A3243G in blood and 
41% in fibroblasts (4). Patient A was a 56 year 
old female with Alport-like renal failure, who 
developed diabetes after kidney transplantation 
at the age of 38, and had a heteroplasmy 
level of 12% A3243G in her blood (8).
Patient GB was a 34 year old female 
diagnosed with non-obese diabetes at the 
age of 16 and a severe hearing disorder. 
As a complication she started to develop 
nephropathy. The A3243G mutation load was 
measured in fibroblast cells and reached 20%.
Patient Wo is a nephew of patient V from the same 
maternal bloodline. He was born in 1965 and 
his A3243G mutation load reached 40% in blood 
platelets. His glucose-tolerance was normal. 
Patient G55 was a 35 year old female when 
diagnosed with MELAS. She developed 
hearing loss and exercise intolerance from the 
age of 25 and her mitochondrial mutation load 
reached up to 32% A3243G in her blood, 55% 
in fibroblast and 61% in muscle. Relatives from 
the female bloodline also suffered from MELAS 
symptoms like strokes and seizures. Additional 
both an aunt and brother developed diabetes.
Trans-mitochondrial cybrids 
In short, 143B-r0 osteosarcoma cells were fused 
with enucleated fibroblasts from the patients, 
thus generating clones with homoplasmic 
as well as different but stable heteroplasmy 
levels for the A3243G mutation. The cybrid 
cells were grown on Dulbecco’s Modified 
Eagle’s medium containing 4.5 mg/ml glucose 
and 110 µg/ml pyruvate (DMEM) supplemened 
with 50 µg/ml uridine and 10% fetal bovine 
serum. Heteroplasmy levels were monitored 
by use of PCR and RFLP using ApaI digestion. 
The oxygen consumption of the cells was 
measured as described previously (7). 
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GeneChip hybridization
Biotinylated cRNA samples were prepared 
according to the Affymetrix GeneChip protocol 
as described previously (9). Several quality-
controls were included. With the intensity-
ratio of the 28S/18S rRNA bands being over 
1.8, the integrity of the RNA was confirmed. 
The optical density at 260 nm compared to 
280 nm was used to verify the purity of the 
sample. Affymetrix’ Microarray Suite 5.0 
Software (MAS) was used to determine the 
percentage of transcripts Present and the 
3’/5’ intensity ratios for b-actin and GAPDH 
as final quality control on the input material. 
Data analysis
Most data analyses were performed in R (www.
r-project.org) using the Bioconductor functions 
(www.bioconductor.org). Intensity data was 
corrected for background arising from optical 
noise as well as from non-specific hybridization, 
according to the procedure developed by Wu et 
al. (10) and annotations were added using the 
annotation package hgu133a, version 1.3.1 (11).
The linear model: signal ~ β1 probe + β2 status + 
β3 patient + ε was fitted to the 2log-transformed 
signals of each transcript. The calculated β’s are 
a measure for the fold change in average signal 
intensity of a transcript between the groups 
compared and are used to obtain p-values for 
the  reliability of the difference. The proportion 
of unchanged genes, 0, was calculated 
according to Storey and Tibshirani (12).
Mitochondrial haplogroup analysis
The mitochondrial haplogroups were analyzed 
using cybrid DNA samples according to 
the method described by Quintáns et al. 
(3). 17 SNPs and the sequence of both 
hyper variable regions of the D-loop 
were used to determine the haplogroups.
Protein synthesis and Western blotting
Protein synthesis was measured as described 
in Chapter 4. Western blots were made 
following a standard protocol from a 10% SDS-
poly-acrylamide gel. 10 µg of protein of the cell 
lysates was used to detect eukaryotic Elongation 
Factor 2 (eEF2, 100 kDa). The anti-bodies were 
used in a 1:1000 dilution and manufactured by 
Cell Signalling Technology, #2332 for eEF2 and 
#2331 for the antibody directed against the 
phosphorylated form of threonine 56 of eEF2. 
Results
Cell characteristics
The cell characteristics including the 
mitochondrial haplogroups of the patients are 
depicted in table 1. As can be seen, the mtDNAs 
of the clones belong to different West-Eurasian 
haplogroups. Haplogroups N* and H6 of 
patients V and GB are the most dissimilar, 
haplogroup R* of patient G55 is the most central. 
The difference between haplogroups J and T is 
the order in which the mutations at locations 
4216 and 10398 have occurred and they are not 
distinguishable with the method used here. 
All cells have, in principle, the same nuclear 
background and the transmitochondrial 
Table 1: Cell characteristics
Cell line  haplogroup  A3243G  O2 consumption
VW1      N*           0 %  1.3
VW2      N*           0 %  1.7
VM1      N*          100 % 0.1
VM2      N*          100 % 0.1
GBW      H6           0 %  1.8 
GBH1      H6           24 % 2.2
GBH2      H6           25 % 2.0
GBH3      H6           29 % 1.9
GBH4      H6           46 % 2.8
GBH5      H6           54 % 2.3
GBH6      H6           76 % 2.4
GBH7      H6           84 % 0.4
GBH8      H6           87 % 1.4
GBM1      H6          100 % 0.1
GBM2      H6          100 % 0.1
WoW      N*           0 %  n.d.
WoM      N*          100 % n.d.
G55M      R*          100 % n.d.
AM     J/T          100 % n.d.
Mitochondrial haplogroups according to 
Quintáns et al. (3) 
Subject Wo is related to patient V
O2 consumption in fmol/min/cell; 
n.d. = not determined
All data are averages of at least 3 
measurements, except for the oxygen 
consumption of cell line GBH4, which is a single 
measurement (see also figure 1).
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cybrid system is therefore focused 
on revealing the effects of mtDNA 
variants on nuclear gene expression. 
Previously we have analyzed the expression 
profiles of the 4 cybrid clones (two homoplasmic 
mutant and two homoplasmic wild type) from 
patient V and found some coherent changes in 
genes grouped according to their function. In 
order to dissect the influences of the A3243G 
mtDNA mutation and haplotype on nuclear 
gene expression with more samples including 
different heteroplasmic mutation loads, we 
have now added 11 cybrid samples from cybrids 
from another A3243G patient (GB). In total 
we thus have used the mRNA of 15 different 
cell lines in two separate comparisons, the 
first is based on respiration status due to 
the A3243G mutation load and the second 
based on the patients-mtDNA haplotype. 
Respiratory status comparison
The mutation load and respiratory status 
of the 11 GB clones is given in table 1 and 
depicted in figure 1. The V clones were all 
homoplasmic with a >10-fold difference in 
oxygen consumption between the wild type 
and A3243G-mutant clones as described in 
Jahangir Tafrechi et al. (9). On the basis 
of these results the respiration status was 
defined as being deficient when clones have a 
mutation load exceeding 75% and as proficient 
with lower heteroplasmy percentages. By 
comparing 9 RNA samples from respiration-
proficient cells to 6 RNA samples from 
respiration-deficient cells, the effect of the 
A3243G mutation was analyzed (respiratory 
status comparison). In figure 2A, the p-values of 
all 22.283 transcripts in the respiratory status 
comparison are represented in a frequency 
histogram. The dashed line represents the 
distribution if truly none of the transcripts 
would have been differentially expressed. 
In other words it represents the histogram 
when the null hypothesis of no differential 
expression between respiration proficient and 
deficient cells is true. According to Storey and 
Tibshirani (12) it corresponds to a π0 value 
of 1, with π0 = m0 / m, where m = the total 
number of transcripts and m0 the number of 
transcripts that are not truly changed. The 
π0 value is based on the false discovery rate 
and represents the proportion of unaffected 
genes.  The π0 value in the respiratory status 
comparison is 0.85. Thus it appears that of all 
the transcripts 85% is actually not changed 
at all in the respiratory status comparison. 
For the genes in the p ≤ 0.02 bin this implies 
a false discovery rate of approximately 1/6th. 
In a search for potentially relevant 
differentially expressed genes we used 
three criteria: t-statistics, fold-change and a 
minimum expression level. For the respiratory 
status comparison 840 transcripts were found 
to be changed when applying a cut-off value of 
p = 0.001 in the t-statistics, 4% of the 22283 
transcripts on the HG-U133A chip (data 
available on request). Only 16 transcripts (2% 
of the 840) in the respiratory status comparison 
Figure 1: oxygen consumption of GB cybrids
The different heteroplasmic cell lines derived 
from mtDNA of patient GB show a threshold 
effect in oxygen consumption and therefore in 
functionality of the respiratory chain. Above 75% 
A3243G the amount of oxygen consumed per 
cell per minute drops from an average 2 to 0,1 
fmol. The standard deviation is calculated from 
minimal 3 independent samples. The variation in 
average mutation load of a particular cell line is 
less than 5%.
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were changed 1.5 fold or more in a signal-to-noise 
ratio analysis (Figure 3). These 16 transcripts 
were checked individually for relative 
expression levels. Most of them express below 
the threshold (defined in the previous chapter 
as <25) except for, eukaryotic translation 
initiation factor 5A, a receptor-like protein 
tyrosine phosphatase and adrenomeddulin. 
We tried to find functionally related groups 
of genes over-represented among the 840 
differentially expressed genes. As in the 
previous chapter we used Gene Set Enrichment 
Analysis (13) to see whether one of the gene 
sets found earlier would give the same small 
but consistent change. The gene sets emerging 
as most enriched in the respiratory status 
comparison include “nucleotide binding”, 
“ribosome” and “MAPK signaling” with 
“ribosome” being the only reoccurring one. 
Patients-mtDNA haplotype comparison
By regrouping the samples into the 4 
independent clones from patient V on one 
side and the 11 clones from patient GB on the 
other, the possible influence of the haplotype 
by itself was analyzed (patient-haplotype 
comparison). The correlation of the 15 GB 
Figure 2: π0 graphs for false discovery percentage calculation
The p-values (x-axis) of all 22.283 transcripts are represented in frequency histograms. The dashed 
line represents the distribution if none of the transcripts would have been differentially expressed and 
corresponds to a π0 value of 1 (y-axis of the corresponding density histogram). The larger the part of 
the histogram under this line the better the correlation of the gene expression profiles. The π0 value for 
the A3243G-respiratory status comparison (A) is 0.85 and for the patient-haplotype comparison (B) it is 
0.27. Note that the y-axes have a different scale.
Figure 3: Fold Change of all 22.283 transcripts in 
the respiratory status comparison
The change in gene expression of non-respiring 
A3243G cells compared to respiring cells is shown 
on a logarithmic scale. Note the absence of 
genes with a > 2 fold change
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and V samples in the patient-haplotype 
comparison and of 4 additional samples is 
visualized in the Pearson’s diagram of figure 4. 
The correlation found in the Pearson’s 
diagram between the samples with the 
same patient-mtDNA haplotype is very 
strong, leading to a clear separation of the 
samples of patient GB with haplogroup 
H6 and patient V with haplogroup N*. 
 The results obtained with four additional 
RNA samples for which expression data were 
available (patients A (one 100% mutant clone), 
G55 (also one 100% mutant clone) and Wo 
(two homoplasmic clones, one wild type and 
one mutant)) corroborate the notion that the 
mtDNA haplotype can influence nuclear gene 
expression. The samples of patients A (M) and 
G55 (M) are both respiratory deficient, but 
Figure 4: Diagram illustrating haplotype correlations of cybrid cell expression profiles
The distances in the tree are calculated according to a Pearson’s correlation test. The shading of the 
boxes correspond to the correlation coefficient as shown in the bar under the figure (the darker the 
color the better the correlation). 
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differ in haplotype. They are clearly separated 
in the correlation diagram (data not shown). 
The two samples of patient Wo (W and M) are 
similar in haplotype but differ in respiratory 
status. Yet, they show strong similarity in 
expression pattern. It should be noted that 
contrary to expectation, RNA samples obtained 
from cybrids with mtDNAs of patient Wo and 
V (nephews from the same maternal bloodline, 
both haplogroup N*) do not appear in the 
same branch. Speculatively, this may be due 
to additional mutations not visible with the 
method used here to define the haplogroups. 
Consistent with the results of the respiratory 
status comparison of the previous paragraph, 
it is clear that no separation between the 
samples on basis of A3243G-respiratory 
status can be made, since both respiration 
proficient and respiration deficient cells 
of a given patient can be found in the 
same branch of the correlation-tree.
In the patient V (haplogroup N*) versus 
patient GB (haplogroup H6) comparison 
9136 or 41% of the 22.283 transcripts are 
changed according to t-statistics with the 
same cut-off p-value of p=0.001 used in the 
respiratory status comparison. Of these a 
total of 297 transcripts (3% of the previous 
selected 9136) are changed over two-fold. A 
batch-wise analysis seemed appropriate to get 
an indication of biologically relevant gene sets 
in this pile of differentially expressed genes. 
The Gene Ontology gene sets most enriched in 
the haplogroup comparison proved to be very 
general like “intracellular” and “cytoplasm”. 
Global translational repression
As in the previous Chapter we measured 
cytosolic translation rates. The cells used 
here have a different haplogroup (patient 
GB, haplogroup H6) compared to the cells 
used in the previous chapter (patient V, 
haplogroup N*), but results are similar: 
protein synthesis rates are 2-4 times lower 
in cells with a high A3243G mutation load 
(Figure 5). As can be seen in figure 5, the 
protein synthesis rate is density-dependent, 
but the mutation-dependent decrease is found 
at every measured density of the cells. Protein 
synthesis is highly demanding on cellular ATP 
(~4 ATPs per peptide bond) and to exclude the 
trivial explanation of dramatic ATP depletion 
cellular ATP content was measured and found 
to be reduced only 20-25% in 100% A3243G 
cybrids (results not shown). It seemed likely 
therefore, that respiratory dysfunction is 
signaled to the cytosolic translation apparatus 
and therefore we choose to investigate the 
activity of proteins involved in controlling 
translation rates, notably initiation and 
elongation factors and their upstream 
regulators, since other cellular stresses 
are known to signal to these proteins (14). 
Figure 6 depicts the signaling framework 
that guided us in setting up the experiments. 
The initial results reported here identify 
elongation factor 2 to be a major target (Figure 7).
Figure 5: Cytoplasmic protein synthesis rates of 
wild type and 100% A3243G cells derived from 
patient GB
The protein synthesis rates and the difference 
between the wild type and mutant rates are 
comparable to those of cells derived from patient 
V, which are shown in Chapter 4 (9). Protein 
synthesis is reflected by 3H-leucine incorporation. 
For gene expression profiling, cells were harvested 
at a density of ~ 40 mg protein/cm2.
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Phosphorylation of EF-2 by eEF2 kinase 
and hence translational repression proved to 
correlate with AMPK phosphorylation (not 
shown). The degree of phosphorylation of EF-2 
in ρ0 (mtDNA depleted) cells is even higher than 
in A3243G 100% mutant cells and correlates 
to both lower oxygen consumption and protein 
synthesis rate. Importantly S6 phosphorylation, 
as a convenient read-out of mTOR activity, 
and phosphorylation of mTOR itself were not 
reduced in A3243G nor ρ0 cells (data not shown)
Discussion
Nuclear gene expression profiles are 
characteristic for the functioning of a cell. 
With oxidative phosphorylation taking a 
central position in energy metabolism and 
thus cell functioning, an effect of OXPHOS 
dysfunction on expression profiles lies 
within reason. Particularly with the A3243G 
pathogenic mtDNA at a heteroplasmy level 
above the critical threshold (when cells 
have lost the ability to respire) we expected 
the nuclear gene expression to be changed 
significantly and by large scale mRNA 
expression analysis we expected to find 
clues of the ‘retrograde signaling’ (that is 
mitochondria to nucleus signaling resulting 
from mtDNA mutation) to further insight in the 
pathobiochemistry of mitochondrial diseases. 
However, using a 1.5-fold difference as a criterion, 
essentially no mRNA expression differences 
were found when comparing A3243G cells on 
basis of respiratory status (Figure 2A and 3). 
Figure 6: Schematic outline of the translation factors and their upstream pathways 
The scheme is adapted from Ruvinsky et al. (34)
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Of the three differentially expressed genes 
eIF5A was potentially interesting in view 
of the translation repression observed 
(Chapter 4 and Figure 5). However its role 
in translation initiation is obscure (15) and 
by far not so well defined as the translation 
factors studied by us such as eIF2α, 4E-
BP1 and eEF2 (Fig 6). In view of their broad 
pathway involvement, the receptor like protein 
tyrosine phosphatase and adrenomedullin 
were not studied further. Thus, at the nuclear 
transcriptional level no strong leads were 
found that may help explain variation in 
clinical phenotype of A3243G mtDNA diseases. 
It seems likely therefore, that under the 
conditions used nuclear transcriptional 
responses to high levels of A3243G mutation 
leading to loss of respiration are subtle.
  
In Chapter 4, the analysis of translation 
rates showed a >2-fold down-regulation in the 
protein synthesis rate in 100 % A3243G cybrid 
cells derived from patients V (haplogroup 
N*). For the A3243G-samples derived from 
patient GB with mitochondrial haplogroup H6 
used here similar results were obtained    In 
these cells ATP is not limiting, thus it appears 
that cells cope with the energy crisis (loss 
of mitochondrial ATP synthesis) by down 
regulating translation by phosphorylation of 
eEF-2, thus saving (glycolytic) ATP for other 
cellular processes. This signalling is mediated 
by AMP-Kinase which recently has been found 
to directly phosphorylate, and inactivate, the 
eEF2 kinase (16).  Noteworthy AMPK is implied 
in mitochondrial biogenesis by activating 
PGC-1α (17), providing a compensatory 
pathway for loss of mitochondrial function. In 
muscle, AMPK phosphorylation also activates 
fatty acid β-oxidation via Acetyl Co-enzyme 
A Carboxylase (ACC) phosphorylation and 
stimulates glucose uptake by increased 
translocation to the plasma-membrane of 
the GLUT4 transporter. These facts may 
illustrate the central role played by AMPK in 
maintaining energy homeostasis: when cells 
consume large amounts of ATP or face problems 
with mitochondrial ATP production (e.g. by 
mtDNA mutation accumulation), AMPK as 
the energy sensor down regulates energy 
demanding anabolic processes and upregulates 
energy releasing catabolic processes. Note 
in this respect that Red-Ragged Fibers as 
found in muscle fibers of mtDNA patients and 
also aged muscles are considered a token of 
mitochondrial biogenesis. It seems reasonable 
to assume that they result from chronic (but 
alas futile) AMPK activation by irreversible 
damage of mitochondria that accumulated 
pathogenic mutations. Down regulating the 
mTOR pathway would be another pathway that 
leads to translational repression. The ongoing 
research confirmed the preliminary S6 results 
and shows that this pathway is not operational 
in the cells used (Janssen et al., in preparation).
Like control of gene transcription, regulation of 
translation (be it globally or mRNA specific) is 
an essential element of gene expression. While 
basics of cytosolic translational control are well 
established, cell- and tissue specific aspects are 
largely unknown. Remarkably in this respect, 
inherited diseases with pathogenic mutation in 
nuclear genes coding for cytosolic translation 
factors or key components of the translation 
machinery are expected to express in all cell 
types and to lead to similar phenotypes. It 
has become clear, however that such nuclear 
gene mutations affect a range of tissues and 
Figure 7: The effect of mitochondrial dysfunction 
on the phosphorylation status of Elongation 
Factor 2
The amount of phosphorylated eEF-2 compared 
to the total amount of eEF-2 is lower in wild 
type cells compared to 100% homoplasmic 
A3243G mutant cells and much lower 
compared to cells depleted of mitochondrial 
DNA (r0). Phosphorylation  inactivates EF-2  and 
consequently protein translation is inhibited.
The total amount of EF-2 is used as  loading 
control.
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organs thus presenting with variable disease 
expression. (For recent authorative review see 
(18)). In this context, our results indicate the 
importance of translational control in response 
to loss of mitochondrial respiratory function. 
In contrast to the pathogenic A3243G 
mutation, the multiple, presumably neutral 
mutations that define a particular haplogroup 
lead to a large number of transcripts that 
show a change in expression level (figure 
2B), indicating that mtDNA haplotype as 
such can modify the nuclear expression 
profile which may or may not predispose to 
disease. We realize that the 143B nucleus is 
genomically instable and this may contribute 
to the observed mRNA expression profile 
changes. However, since in the respiratory 
status comparison hardly any changes in 
gene expression profiles were found we 
conclude that such contributions will be minor. 
Several studies, ranging from mouse behavioral 
studies to human mtDNA association studies, 
have been carried out to search for an effect 
of mtDNA haplotype on phenotype. The mouse 
model study by Roubertoux et al. (19), makes 
a strong point in this respect. Cross transfer of 
a different mtDNA haplogroup modified brain 
anatomy, sensory development and learning 
abilities in nuclear congenic mice, indicating 
that mitochondrial polymorphisms may not 
be as neutral as is generally believed. Indeed, 
very recently it was reported that a naturally 
occurring variation in the mitochondrial genome, 
independent of nuclear genome variation, is 
a risk factor for type 2 diabetes in rats (20) 
On the other hand, an association study in 
Spain (20) reports that mitochondrial DNA 
haplogroup does not play a significant role 
in the variable phenotypic presentation of 
the A3243G mutation, based on data of 35 
independent patients. Several studies have 
attempted to associate common mitochondria 
haplotypes with common diseases such as 
diabetes (22;23), cancer (24;25), cardiovascular 
diseases (26), Parkinson’s (27) and Alzheimers 
Disease (28;29) as well as with longevity (30) 
often with inconsistent results. Likely this 
is related to issues known to affect results of 
genetic association studies such as sample 
size, matching of cases, controls regarding 
geographical origin and ethnicity and 
phenotyping and data analysis quality (31;32).
Based on the observation that the analyzed 
mtDNA haplogroups differ quite dramatically 
in gene expression profile, we tentatively 
conclude that mtDNA haplogroup can modify 
nuclear gene expression. This would supports, 
the notion that mtDNA haplogroup may 
predispose to common diseases. The changes 
we found between the haplogroups were 
randomly distributed over Gene Ontology 
pathways and numerous, implying that 
should a significant association between 
a haplogroup and a common disease be 
unambiguously proven, it will be difficult 
to molecularly disentangle the contribution 
of haplotype to the predisposition (33).
In conclusion, subtle differences in mRNA 
expression profiles between respiratory 
deficient and proficient A3243G cells likely 
prevented us from identifying genes that 
are implied in signaling from a defective 
mitochondrial compartment to the nucleus. 
Thus at the nuclear transcriptional level 
no leads were found to tissue and cell type 
specific responses that may help explain 
variation in clinical phenotype of A3243G 
mtDNA diseases. Large differences were, 
however, found when mtDNA haplogroups 
were compared for nuclear gene expression, 
indicating that mtDNA sequence variants per 
se can affect nuclear expression programs. 
At the translational level, a clear effect 
was observed: global cytosolic translational 
repression mediated by AMPK and elongation 
factor eEF2 was identified, indicating the 
importance of translational control in response 
to loss of mitochondrial respiratory function 
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Introduction
The multicopy 16.569 bp circular DNA of 
the mitochondrial compartment codes for 13 
of the ~90 protein subunits of the oxidative 
phosphorylation system and 24 RNAs involved 
in mitochondrial protein synthesis of these 
13 protein subunits. mtDNA mutates at a 
rate 5–10 fold higher than nuclear DNA. 
Deleterious mutations in mtDNA, be it in 
tRNA, rRNA or protein coding regions, will 
affect oxidative phosphorylation. However, 
this will only become overt at the cellular 
level if the mutation is present in the 
majority of the cell’s mtDNA molecules. 
A remarkable feature of inherited mtDNA 
diseases is that a specific mtDNA point 
mutation can express in highly variable 
clinical phenotypes. This is remarkable 
because mtDNA mutations are assumed 
to segregate randomly from the fertilized 
heteroplasmic oocyte onwards, predicting 
much more common disease phenotypes. It 
has been proposed that non-random, but as 
yet enigmatic segregation mechanisms are 
responsible for variable disease expression. 
In recent years it has become apparent that 
mtDNAs are organized in so-called nucleoids 
with multiple mtDNAs per nucleoid (1-3), 
but only little is known how this organization 
impacts on segregation of mtDNA mutations (2). 
While it is indeed evident that mtDNA 
mutation accumulation needs to occur, it has 
also been suggested that variability in disease 
expression may result from aberrant mtDNA 
gene products, interacting in complex ways 
with the mitochondrial-nuclear cross-talk and 
thus affecting tissues and cells in different 
ways with –to complicate things further- 
influences from the nuclear genetic background 
and mtDNA haplotype. A highly relevant 
mtDNA mutation in this ‘one mutation-many 
phenotypes’ respect is the A3243G mutation 
in the MTTL-1 encoding mt-tRNA-Leu(UUR) (4).
The goal of this Thesis has been to shed 
more light on the complex pathways from the 
pathogenic A3243G mtDNA mutation to the 
phenotypical consequences by conducting, 
with well defined in vitro cell culture 
models of the A3243G mtDNA mutation, 
segregation research and whole genome 
expression analysis for characterization of 
mitochondria-to-nucleus signaling. Ideally one 
would of course conduct such research with 
in vivo systems such as a mouse model, but 
manipulation of mtDNA in vivo is impossible. 
This explains the lack of animal models for 
the A3243G and other deleterious mtDNA 
mutations, although prospects are good 
for mouse models that are heteroplasmic 
for pathogenic point mutation (see below).
Methods for analysis of mitotic A3243G 
mtDNA segregation
mtDNA segregation research requires single 
cell mutation analysis so as to be able to follow 
cellular mtDNA inheritance patterns. To get 
sufficient data, many individual cells need to 
be analyzed, e.g. in serial passages. Thus a 
high throughput assay needed to be developed. 
The relatively large number of mtDNA 
molecules in a cell readily allows single PCR 
amplification of the mtDNA region of interest, 
but the characteristics of the A3243G mutation 
(an A to G transition, a GC-rich environment 
and location in a region prone to hairpin 
formation), however, prohibited closed-tube 
fluorescent PCR assays on basis of Molecular 
Beacons or Taqman probes. 
Polymerase Chain Reaction - Restriction 
Fragment Length Polymorphisms (PCR-
RFLP) is a time honored mutation detection 
technology and has often been applied for 
A3243G mutation detection and quantization 
on bulk DNA. The procedure involves in 
the final manual steps, restriction enzyme 
digestions, gel electrophoresis, optionally 
Southern hybridization and image analysis. 
The workload inherent to such techniques, 
however, severely limits throughput. We 
therefore developed two alternative strategies. 
One is based on PCR-RFLP, but by-passes 
electrophoresis. It uses melting temperature 
characteristics of the PCR fragments to detect 
and quantify the mutation level after single 
cell PCR; hence it is referred to as PCR-RFMT. 
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The only compromise of PCR-RFMT to a 
closed tube-assay is the one time addition of 
the restriction enzyme. The other method is an 
in situ approach. It uses the high sensitivity 
of DNA ligases to mismatches in a padlock 
hybridization strategy. Additionally it uses 
φ29 DNA polymerase mediated rolling circle 
amplification of the circularized padlock for 
detection of wild-type and mutant mtDNA 
molecules in situ and automated image 
analysis for quantitation purposes. Both 
methods have the requisite throughput and 
are of sufficient accuracy (Standard Deviations 
of ~5%) for single cell-based segregation 
analysis. In the 0 – 25% mutation load range, 
however, PCR-RFMT is less accurate than 
padlock/RCA due to the square root relation 
between the measured and actual mutant load.
Suppressed and quantal mitotic A3243G 
segregation in vitro 
With these newly developed methods it was 
shown with heteroplasmic cybrid cultures 
that the mutation load of descendants of 
three founder cells heteroplasmic for the 
A3243G mutation did not change mutation 
load, while computer simulations of random 
mitotic segregation showed that considerable 
changes should have occurred in consecutive 
passages of the three clones (see page 40, 
H3). This supports the faithful replicating or 
stable nucleoid model described by Jacobs et 
al. (5). With a fourth A3243G clone (V_50), 
discrete or ‘quantal’ shifts in mutation load 
occurred. Such a pattern is also incompatible 
with random segregation. To explain the 
stable heteroplasmy and the discrete shifts, 
we postulated the mitochondrial nucleoid 
to be a genetically meta-stable segregation 
unit. This implies that most of the time the 
nucleoid is in a stable phase, replicating 
its mutation load faithfully and thereby 
effectively suppressing segregation. When 
occasionally in an unstable phase, genetic 
rearrangements or unfaithful replication 
gives rise to nucleoids of altered heteroplasmy 
which rapidly segregate randomly to daughter 
cells to yield descendant cells of variable, but 
discrete heteroplasmy levels. We provided 
arguments that nuclear determined growth 
advantage enables us to see the significant 
subpopulation with altered heteroplasmy. 
As indicated in Chapter 3, a second series of 
long term segregation experiments has been 
initiated. To this end  cells of passage 42 of 
V_50 were sub-cloned and analyzed up to 
passage ~100, expecting some of them to be 
stable and some to shift to either wild type or 
mutant. Figure 1 shows preliminary results of 
two subclones.  Subclone V_3.2 (mtDNA copy 
number is ~1800) hardly showed change in 
cellular mutation loads from passage 1 up to 81 
while according to random segregation model 
it should. V_3.18 proved unstable. It shifted, 
in contrast to V_50, toward mutant. Cells in 
passage 1 peaked at 35-45% heteroplasmy; cells 
in passage 63 at 65-75%.These observations 
substantially strengthen the notion that 
the nucleoid is metastable and that it is a 
nuclear, not mitochondrial determined growth 
advantage that enables us to see significant 
subpopulations of cells with a given altered 
heteroplasmy as it is very unlikely that 
increasing mtDNA mutation loads provide 
growth advantage. From the pattern seen with 
V_3.18 it is inferred that early in the outgrowth 
of the founding V_3.18 cell, nucleoids with a 
higher heteropasmy emerged that following 
their segregation ‘hitchhiked’ with cells having 
slight nuclear determined growth advantages.
Literature indicates that physically 8-10 
mtDNA molecules are present per nucleoid in 
the 143B cells used here. The heteroplasmy 
levels found in this thesis are compatible 
with this estimate, but more work is needed 
to arrive at the exact ‘quantal’ number, 
to document cell type dependence and to 
answer the question whether or not the 
meta-stable nucleoid model holds for neutral 
and other pathogenic mtDNA mutations. 
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Figure 1: Single cell mutation load histograms of A3243G heteroplasmic mtDNA of two 143B 
transmitochondrial cybrid subclones derived from clone V_50 passage 42
For the experimentally generated graphs the mutation loads (x-axis) of individual cells were measured 
by Padlock/RCA as described in Chapter 2 relative amount of cells are shown (z-axis) for two, far 
separated, passages (y-axis).
V_3.2 (~1800 mtDNAs per cell) is a stable clone with a mutation load peak in the 65-70% bin at both 
passage 1 and passage 81, corresponding to 40 weeks of culturing. 
As comparison a simulation was run for the random segregation model, starting from a single cell with 
a mutation load corresponding to the average mutation load of V_3.2 in passage 1 and 2000 mtDNAs. 
Note the considerable percentage of homoplasmic mutant cells in the simulation of passage 81.
V_3.18 is an unstable clone which shows cellular heteroplasmy shifts towards mutant, in contrast to 
clone V_50 which showed drift towards wild type. The peak for V_3.18 at passage 1 is in the  35-45 % 
and at  passage 63 in the 65-75 % range.
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A role for nucleoids in vivo ?
The in vitro observations described in this 
Thesis strongly indicate that non-segregation 
(segregation suppression) rather than random 
segregation is the rule for mtDNA. An in 
vivo consequence of segregation suppression 
mediated by nucleoids would be that it provides 
for an alternative mechanism of maintaining 
mtDNA genotypical integrity in the face of 
high mutation rates for mtDNA (5). A faithfully 
replicating nucleoid can indeed accommodate 
many different mutations without giving 
descendants of high heteroplasmy. The 
classical view is that the relative high copy 
number of mtDNA protects descendant cells 
against mtDNA mutation accumulation 
by random genetic drift of naked mtDNA 
molecules, but this protection is more limited. 
It will require pathogenic heteroplasmic mouse 
model studies to objectively make distinction 
between the two views of protection against 
mtDNA mutation accumulation. The mtDNA 
mutator mouse which accumulates mtDNA 
mutations (and suffers from a wide range of 
age-associated conditions) provides a means 
to construct pathogenic heteroplasmic mouse 
models, because it allowed for the first time 
introduction of random mutations in the 
mtDNA (6-8). To generate heteroplasmic 
mouse models, female mutator mice can be 
crossed to male wild-type mice to obtain mouse 
strains carrying specific mtDNA mutations 
because of the (elusive) mitochondrial 
bottleneck in early embryogenesis 
(Larsson NG, personal communication).
In view of the large size of the germline 
mtDNA bottle neck recently reported in 
mice (9), it is tempting to speculate that 
genetic reorganization of nucleoids in early 
embryogenesis lies at the heart of the ’bottle 
neck’. Heteroplasmic mouse models with 
GFP marked germ line cells in combination 
with quantitative in situ genotyping methods 
such as padlock/RCA may provide the 
means to test the idea of a developmentally 
controlled reorganization of nucleoids. 
Similarly, such mice and methodology 
will allow the study of the role of nucleoid 
(re) organization in pathogenic mtDNA 
segregation in somatic cells and tissues.
Mitochondrial-nuclear crosstalk in A3243G 
cybrid cells
Next to mutation accumulation by still elusive 
segregation mechanisms, it has been suggested 
that mtDNA disease expression is modulated 
by aberrant mtDNA gene products, interacting 
in complex ways with the mitochondrial-
nuclear cross-talk and thus affecting tissues 
and cells in different ways. To obtain insight 
in effects of A3243G mutations on the nuclear 
expression profile we conducted genome-
wide expression studies of A3243G cell clones 
that are respiration deficient and proficient 
Results with our well defined in vitro cell 
modelled us to conclude that the number 
of genes changed ≥ 1.5-fold in expression 
is minimal, indicating that adaptation of 
the nuclear transcription program to loss of 
mitochondrial respiration because of A3243G 
mutation accumulation are more subtle.
Much more differential gene expression was 
found when two haplogroups were compared, 
a fact that may indicate that mtDNA sequence 
variants can modulate phenotypic expression.
 
Global translational repression
The fact that, given the sensitivity of the 
expression analysis, no nuclear response to 
loss of respiration was observed, prompted us 
to investigate post-transcriptional responses 
of the A3243G mtDNA mutation. A strong 
effect on global protein synthesis rates was 
consistently observed. In terms of disease 
development where mitochondrial dysfunction 
is implicated, such as diabetes, this finding 
is of great significance. Pancreatic β-cells are 
the most active protein synthesizing cells, 
demanding vast amounts of energy. Obviously 
translation of preproinsulin mRNA is a major 
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task of the β-cell’s protein synthesis machinery 
and the process uses 25 to 30% of all ATPs 
produced. Thus a mitochondrial dysfunction 
in a pancreatic β-cell, be it by accumulation 
of inherited or acquired mtDNA mutation 
or by environmental or dietary factors, 
will negatively affect insulin production. 
In fact it acts as a double edged sword: 
it also derails glucose-stimulated insulin 
secretion because of its strong dependence 
on increased mitochondrial ATP production 
in response to elevated blood glucose levels.
With ATP levels marginally affected in A3243G 
cells, it was obvious that signalling from the 
defective mitochondria to the cytosolic protein 
synthesis machinery must occur. Screening 
a number of translation factor candidates 
for phosphorylation, identified elongation 
factor 2 (eEF-2) and initiation factor 2α 
(eIF-2α) as effector targets of the signaling 
pathway (Janssen et al., in preparation). 
Phosphorylation of eIF-2α leads to translation 
inhibition by preventing initiation. Of its four 
known kinases, PERK which is activated 
upon ER-stress (10), is the most likely 
candidate, because extensive mitochondrial-
endoplasmatic interactions are known to exist 
and their perturbation lead to ER-stress (11;12).
eEF2 is the translation factor that controls the 
most energy demanding step of translation: 
elongation (4 ATP equivalents  per peptide 
bond). Phosphorylation of eEF2 by its only 
known kinase (eEF2kinase) leads to inhibition 
of protein synthesis. eEF-2 kinase is regulated 
directly (13) as well as indirectly (via mTOR) by 
the cellular energy sensor AMP-kinase, which 
indeed was found activated (Janssen et al., 
in preparation). In all, these results show the 
importance of translational control in response 
to loss of mitochondrial respiratory function 
Concluding remarks
By development and application of newly 
developed methods for single cell A3243G 
mtDNA heteroplasmy measurements, it was 
found that segregation of mtDNA as a rule 
is absent in in vitro cultured A3243G cybrid 
cells. The nucleoid, a mitochondrial matrix 
nucleoprotein complex carrying 8-10 mtDNA 
molecules, likely mediates this segregation 
suppression by faithfully replicating its mutant/
wild type ratio. Occasionally discrete shifts 
in heteroplasmy were observed, suggesting 
that a transient genetic rearrangement 
of the nucleoid may underlie segregation.
Subtle differences in nuclear mRNA expression 
profiles between respiratory deficient and 
proficient A3243G cells likely prevented us 
from identifying genes that are implied in 
signaling from defective mitochondria to the 
nucleus. Thus at the nuclear transcriptional 
level no leads were found to tissue and 
cell type specific responses that may help 
explain variation in phenotype of A3243G 
mtDNA diseases. However, global repression 
of cytosolic translation, mediated by at least 
two translation factors, was identified as 
a major adaptation to loss of respiration. 
This may indicate an important role for 
translational control mechanisms in response 
to loss of mitochondrial respiratory function.
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Summary
Mitochondria are involved in a number of cellular processes of which energy metabolism, notably 
oxidative phosphorylation, is an important one. Oxidative phosphorylation accounts for ~80% 
of cellular ATP production and occurs in the mitochondrial inner membrane. The ~90 protein 
subunits of the 5 Complexes involved in this process are mostly nuclear encoded, but 13 of them 
are encoded on mitochondrial DNA (mtDNA). Next to these protein genes, the mitochondrial 
DNA codes for 22 mitochondrial tRNAs and 2 rRNAs, which are essential for translation of the 
13 mtDNA encoded mRNAs. Mutations in these 37 mtDNA genes can cause disease. Remarkably, 
one specific mtDNA mutation can cause different syndromes. A relevant example is the A3243G 
mutation. This mutation is in the MMTL-1 gene, coding for tRNA-leu(UUR), and associates with 
Maternally Inherited Diabetes and Deafness (MIDD), but it is also causes Mitochondrial 
Myopathy Encephalopathy Lactic Acidosis and Stroke-like episodes (MELAS) as well as Chronic 
Progressive External Opthalmoplegia (CPEO). 
A cell may contain 100s to 1000s of maternally inherited mtDNA molecules and a mutation 
can occur in all or in a fraction of the mtDNAs. Above a given threshold of mutation load 
(heteroplasmy) cells will stop producing mitochondrial ATP. Accumulation of the A3243G 
mutation can therefore lead to energy stress and consequently be a cause of cell and organ 
dysfunction. To explain clinical heterogeneity, it has been proposed that in interaction with the 
nuclear genome, tissue and cell specific effects cause diversity in accumulation of the A3243G 
mtDNA mutation. It has also been suggested that signalling from defective mitochondria to 
the nuclear expression program (the retrograde response) underlies diversity of the clinical 
phenotypes, but mechanisms and relative contributions of these not mutually exclusive processes 
are elusive. This thesis attempted to contribute to a better understanding of these processes 
by studying segregation mechanisms underlying mutation accumulation as well as by studying 
which nuclear genes and cellular processes alter expression under A3243G mtDNA mutation. To 
this end transmitochondrial cybrids clones have been used: cells in which the original mtDNA is 
replaced by mtDNA from A3243G carriers in a homoplasmic or heteroplasmic fashion.
With respect to mtDNA mutation accumulation, it has become clear in recent years, that 
mtDNAs do not occur in the cell as single mtDNA molecules but that they are organized in 
so-called nucleoids, with multiple mtDNAs being present in a nucleoid. How heteroplasmy is 
accommodated by this nucleoid organization and how it mediates mtDNA segregation is poorly 
understood.  
A few studies reported, by bulk DNA analysis, stable heteroplasmy in long term, non-selective 
cultures of A3243G cybrid clones, but also heteroplasmy shifts to either wild type or mutant 
were seen.  By single cell mutation analysis at a time point where random segregation should 
have been obvious by appearance of homoplasmic cells (genetic fixation), it was found in one 
study that the individual cells of stable clones still had the original  heteroplasmy; they had not 
segregated their mtDNAs  It led to the concept of a multi-copy mtDNA segregation unit, the 
nucleoid,  that is heteroplasmic itself and that replicates its wild type/mutant content faithfully. 
To explain changes in heteroplasmy, as occurs in shifting cybrid clones, it was speculated that 
the faithfully replicating nucleoid  may occasionally reorganize its wild type/mutant ratio, 
possibly under genetic control. Likely due to lack of semi-high throughput single cell mutation 
load measurements, experimental evidence for this meta-stability of nucleoids lying at the base 
of segregation in shifting A3243G clones is however absent. 
Chapter 2 describes development of two methods to determine the A3243G mutation load of 
single cells in relatively high-throughput. 
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The hybridization-based methods are concerned with a difficult AG transition. The AT bond of 
the wild type/wild type hybrid is energetically comparable to the GT mismatch and the mutation 
is located in a GC-rich environment that additionally is prone to hairpin formation. Because of 
these limitations, single cell PCR based Taqman or Molecular Beacon assays were not feasible. 
Two alternatives were, however, successfully developed in Chapter 2. One is based on PCR-
RFLP of single sorted cells. Instead of gel-based analysis it uses the melt characteristics of the 
restriction fragments to quantify mutation loads. The other is a bi-colour in situ genotyping 
approach that uses so-called padlock probing in combination with rolling circle amplification for 
detection of the genotypes as red and green dots and image analysis for their quantitation. Both 
methods perform equally well in terms of throughput and accuracy.
In Chapter 3 (and 6) the methods were applied to shifting and stable A3243G cybrid clones, 
cultured under non-selective conditions. When analyzed at the single cell level the shifting 
clones (one to wild type, one to mutant) proved to show discrete shifts in cellular heteroplasmy. 
This can not be easily reconciled with a random segregation mechanism, not even in combination 
with replicative mtDNA advantages and cellular selection. As illustrated in Figure 3 of Chapter 
3 appearance of cells with an altered heteroplasmy can be explained with  the meta-stable 
nucleoid model. The meta-stable nucleoid model predicts that clones can dwell in a state of non-
segregation for extended periods of time. Support for this stable element of the model came 
from 4 additional clones analyzed: experimentally generated histograms of mutation loads 
were compared with computer simulated histograms generated on basis of a random mtDNA 
segregation model. The individual cells in these clones maintained heteroplasmy much longer 
than expected on basis of random segregation, pinpointing to considerable genetic stability of 
the heteroplasmic segregation unit. These experimental results indicated for the first time how 
nucleoids can mediate mtDNA segregation. 
The nuclear gene expression pattern is influenced by many factors and the cell’s demand for 
energy is amongst them. If and how the A3243G mtDNA mutation, at heteroplasmy levels that 
compromise energy metabolism, is redirecting the nuclear genome’s expression profile has been 
examined in the cybrid system with mtDNA sequence variation being in principle the only 
variable. By the use of a DNA chip permitting analysis of 22.283 gene transcripts simultaneously, 
the gene expression profiles of cybrids heteroplasmic and homoplasmic for the A3243G mutation 
in two different mtDNA haplogroup backgrounds were compared in Chapters 4 and 5. Thus 
comparisons on basis of respiration status and haplogroup could be made independently. Where 
it stood to reason that substantial RNA gene expression differences are present between 
respiring and non-respiring cell hardly any > 1.5 fold changes were found when their profiles 
were compared. In sharp contrast hundreds of differences were found when comparing cells with 
the different mitochondrial DNA haplogroups. This indicates that the haplotype can as such 
affect nuclear gene expression. The fact that in the respiratory status comparison hardly any 
changes were found indicated that, in the cybrid system, adaptations of the nuclear expression 
profile to the loss of mitochondrial ATP production were either to small to be identified by our 
analytical approach or that these cells have adapted by post-transcriptional mechanisms. Indeed 
global translational repression appeared to be a major adaptive (energy saving) pathway. This 
repression is mediated by phosphorylation of Elongation factor 2 (eEF-2) and initiation factor 2 
(eIF-2). Upstream of eEF-2 is eEF-2 kinase which is activated by the cell’s energy sensor AMP-
activated kinase (AMPK). Importantly, the eIF-2 phosphorylation indicates involvement of the 
endoplasmatic reticulum resident kinase PERK and identifies ER-mitochondrion interactions in 
energy stress sensing, independent of the AMPK route. 
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In conclusion, likely due to low level changes in gene expression, no genes or gene sets could be 
identified with gene wide expression analysis that would hint to the molecular pathways that 
are altered upon loss of mitochondrial ATP production as a consequence of A3243G mtDNA 
mutation. Extensive post-transcriptional adaptation in the form of global translation repression, 
was however apparent. A comparison between two mtDNA haplotypes indicated, that these 
presumably neutral sequence variants can affect the nuclear expression program, which 
tentatively indicates that mtDNA haplotype can affect phenotype. 
Finally, using newly developed single cell A3243G mutation load assays a novel mechanism 
of mtDNA segregation was identified in which the multi-copy mtDNA nucleoid takes a central 
position.
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Samenvatting 
Mitochondriën zijn betrokken bij verschillende cellulaire processen waarvan energie metabolisme, 
met name  oxidatieve fosforylering, een belangrijke is. Oxidatieve fosforylering neemt zo’n 80% 
van de cellulaire energieproductie in de vorm van ATP voor z’n rekening en vindt plaats in 
het mitochondriële binnenmembraan. De genetisch code van de meerderheid van de  ~90 eiwit 
subeenheden van de 5 complexen betrokken bij dit proces is in het kern DNA vastgelegd, maar 
13 subeenheden zijn op het  mitochondriëel DNA (mtDNA) gecodeerd. Naast deze eiwitgenen 
bevat het mtDNA de codes voor 22 mitochondriële tRNAs en 2 rRNAs, die essentieel zijn voor de 
translatie van de 13 mitochondriële mRNAs. Mutaties in deze 37 mtDNA genen kunnen ziekten 
veroorzaken. Opmerkelijk daarbij is dat één specifieke mutatie verschillende ziektebeelden 
kan veroorzaken (klinische heterogeniteit). Een relevant voorbeeld is de A naar G transitie op 
locatie 3243. Deze mutatie bevindt zichin het MTTL-1 gen, dat codeert voor het tRNA-Leu(UUR) 
en associeert met een bepaalde vorm van diabetes (MIDD: Maternally Inherited Diabetes 
and Deafness), maar ook met aandoeningen aan het neuro-musculaire systeem (MELAS: 
Mitochondrial Myopathy Encephalopathy Lactic Acidosis and Stroke-like episodes) en de 
oogzenuw (CPEO: Chronic Progressive External Opthalmoplegia). 
Een cel kan honderden tot duizenden van de moeder geërfde mtDNA moleculen bevatten en 
een mutatie kan in alle of in een gedeelte van de mtDNAs voorkomen. Boven een bepaalde 
grenswaarde van de mutatiegraad (heteroplasmie) zullen de cellen stoppen met het produceren 
van mitochondriëel ATP. Ophoping van de A3243G mutatie kan dus leiden tot energie stress 
en daarmee tot disfunctie van cellen en organen. Om de klinische heterogeniteit te verklaren 
is er voorgesteld dat weefsel- en cel specifieke effecten, in combinatie met de werking van het 
kern genoom, verscheidenheid in ophoping van de A3243G mtDNA mutatie kunnen veroorzaken. 
Daarnaast wordt er gedacht dat signalen van niet goed functionerende mitochondriën naar de 
kern (de retrograde respons) aan de verscheidenheid van klinische fenotypen ten grondslag 
liggen. De mechanismen en relatieve bijdragen van deze elkaar niet uitsluitende processen zijn 
onduidelijk. Dit proefschrift probeert bij te dragen aan een beter begrip van deze processen 
door het bestuderen van enerzijds  segregatie-mechanismen die mutatieophoping veroorzaken en 
anderzijds de expressie veranderingen van kerngenen en cellulaire processen die optreden ten 
gevolge van  A3243G mtDNA mutatie. Hiervoor is er gebruik gemaakt van cybride cellen: cellen 
waarin het originele mtDNA is vervangen door homoplastisch dan wel heteroplastisch mtDNA 
van dragers van de A3243G mtDNA mutatie.
Het is de laatste jaren duidelijk geworden dat mtDNAs niet als losse moleculen in de cel 
voorkomen, maar dat ze georganiseerd zijn als groepjes in eiwit-DNA structuren die  nucleoiden 
genoemd worden. Of en hoe deze nucleoiden zelf heteroplastisch zijn  en hoe ze bijdragen aan 
mtDNA segregatie is echter onduidelijk. Enkele studies rapporteren, door analyses van het 
gemiddelde mutatieniveau, stabiele heteroplasmie tijdens het langdurig en niet-selectief kweken 
van A3423G cybride klonen, maar onder deze omstandigheden zijn er ook veranderingen in 
heteroplasmie niveau richting zowel wild type als mutant gevonden. Door middel van analyse van 
de mutatiegraad in individuele cellen op een tijdstip dat er volgens een segregatie mechanisme 
op basis van willekeur homoplastische cellen aanwezig zouden moeten zijn (het principe van 
genetische fixatie), is er in slechts één studie gevonden dat de cellen hun mtDNA niet segregeren, 
maar de originele mutatiegraad behouden. Dit heeft geleid tot het concept van een segregatie-
eenheid met meerdere mtDNAs, het nucleoid, dat zelf heteroplastisch is en de wildtype/mutant 
sequentie tijdens replicatie exact behoudt. Om veranderingen in heteroplasmie te verklaren is 
er gespeculeerd dat het  betrouwbaar replicerende nucleoid bij tijd en wijle de wild type/mutant 
ratio kan veranderen, mogelijk  onder invloed van een genetisch programma. 
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Waarschijnlijk ten gevolge van gebrek aan individuele cel mutatiegraad metingen op grote 
schaal, is de experimentele bewijsvoering voor meta-stabiele nucleoiden als basis voor segregatie 
in veranderende A3243G klonen echter  nog niet geleverd. 
Hoofdstuk 2 beschrijft de ontwikkeling van twee methoden om de A3243G mutatiegraad te 
bepalen in individuele cellen op een relatief grote schaal. Op hybridisatie gebaseerde methoden 
moeten in dit geval werken met een lastige A naar G transitie. De AT binding van het wildtype/
wildtype hybride  is namelijk energetisch vergelijkbaar met de GT binding van het mutant/
wildtype hybride,  en daarnaast is de mutatie gelokaliseerd in een GC-rijke omgeving die ook 
nog eens makkelijk  een secundaire structuur vormt. Vanwege deze beperkingen zijn op Taqman 
of Molecular Beacons gebaseerde PCR benaderingen niet haalbaar gebleken. Twee alternatieven 
zijn echter met succes ontwikkeld in hoofdstuk 2. Een methode is gebaseerd op PCR-RFLP 
van het mtDNA van individueel gesorteerde cellen. Hierbij wordt voor de kwantificering  in 
plaats van de gebruikelijke gel-analyse gebruik gemaakt van de smelt-eigenschappen van de 
restrictie fragmenten  De andere methode is een twee-kleurige in situ genotypering, waarbij 
zogenaamde padlock probes in combinatie met rolling circle amplification worden gebruikt voor 
detectie van de genotypen. De genotypen worden als rode en groene stippen zichtbaar en door 
middel van beeldanalyse gekwantificeerd. Beide methoden voldoen goed in termen van snelheid 
en nauwkeurigheid.
In hoofdstuk 3 (en 6) zijn de methoden, toegepast bij A3243G cybride klonen die onder neutrale 
condities in continue kweek zijn gebracht. Metingen op individueel celniveau van klonen, die 
in gemiddelde mutatiegraad veranderden (een richting wild type en een richting mutant) laten 
discrete veranderingen zien in cellulaire heteroplasmie. Dit feit kan niet eenvoudig worden 
verklaard met een random segregatie mechanisme, zelfs niet in combinatie met mtDNA replicatie 
voordeel en cellulaire selectie. Zoals getoond in figuur 3 van hoofdstuk 3, kan het voorkomen van 
cellen met een veranderende mutatiegraad verklaard worden met het genoemde meta-stabiele 
nucleoid model. 
Dit model voorspelt dat heteroplastische klonen gedurende langere tijd segregatie kunnen 
vermijden. Onderbouwing van dit stabiele element van het model is verkregen  met de analyse 
van vier extra klonen, waarbij de experimenteel gegenereerde histogrammen voor mutatiegraad 
vergeleken zijn met computer gesimuleerde histogrammen uitgaande van een random segregatie 
model. De individuele cellen in deze vier klonen behielden de originele mutatiegraad veel langer 
dan verwacht op basis van random segregatie, wat duidt op significante genetische stabiliteit van 
het nucloid als heteroplastische segregatie-eenheid. Deze experimentele resultaten geven voor 
het eerst aan hoe nucleoiden heteroplasmie accommoderen en segregatie kunnen beïnvloeden.
Het nucleaire expressie patroon is een resultaat van vele factoren, waarvan de energie-behoefte 
van de cel er een is. Of en hoe de A3243G mutatie, bij zo’n hoge heteroplasmie dat het energie 
metabolisme is aangedaan, het nucleair expressie patroon veranderd, is onderzocht in het cybride 
systeem waarbij de mtDNA sequentie in principe de enige variabele is. Gebruik makend van een 
DNA chip waarmee 22.283 gen transcripten tegelijkertijd geanalyseerd kunnen worden, is in 
hoofdstukken 4 en 5 het genexpressie profiel van heteroplastische en homoplastische A3243G 
cybriden in combinatie met twee verschillende mtDNA haplotypes vergeleken. Dus onafhankelijk 
van elkaar konden vergelijkingen gemaakt worden op basis van ademhalingscapaciteit (een 
maat voor oxidatieve fosforylering) en haplogroep. Tegen de verwachting in zijn er nauwelijks 
verschillen in RNA expressie gevonden van 1,5 keer of meer tussen wel en niet ademhalende 
cellen. Dit staat in tegenstelling tot de honderden verschillen die gevonden zijn in de vergelijking 
van de twee mitochondriële haplogroepen, wat een indicatie geeft dat het haplotype  op zich het 
nucleaire gen expressie patroon zou kunnen beïnvloeden. 
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Het feit dat in het ademhalingsvergelijk nauwelijks verschillen zijn gevonden geeft aan dat, in 
het cybride systeem, aanpassingen aan het nucleaire expressie profiel ten gevolge van het verlies 
aan mitochondriëel ATP productie te klein waren om door onze analyse te worden geïdentificeerd 
of dat deze cellen zich post-transcriptioneel hebben aangepast. Algemene translatie remming 
blijkt inderdaad een belangrijke energie-besparende pathway. Deze remming wordt beïnvloed 
door fosforylering van Elongation factor 2 (eEF-2) en initiation factor 2 (eIF-2). Upstream 
van eEF2 bevindt zich eEF2-kinase welke geactiveerd wordt door het AMPK-geactiveerd 
kinase (AMPK), de energie-sensor van de cel. Fosforylering van eIF-2 duidt op betrokkenheid 
van het endoplasmatisch reticulum kinase PERK en identificeert interactie tussen het ER en 
mitochondriën onafhankelijk van AMPK als energie stress sensor. 
Concluderend, waarschijnlijk door kleine veranderingen in gen expressie niveau’s zijn er geen 
moleculaire processen gevonden die betrokken zijn bij de reactie op verlies van mitochondriële 
ATP productie door de A3243G mtDNA mutatie. Wel is een duidelijke post-transcriptionele 
aanpassing in de vorm van algemene translatie remming vastgesteld. Vergelijking van twee 
mtDNA haplogroepen wijst er verder op dat neutraal veronderstelde mtDNA sequentie varianten 
een effect op het nucleaire expressie profiel hebben, wat gevolg zou kunnen hebben op expressie 
van fenotype. Tenslotte, gebruik makend van zelf ontwikkelde individuele mutatiegraad 
bepalingen is er een nieuw mechanisme voor mtDNA segregatie gepostuleerd, waarbij het 
meerdere mtDNAs bevattende nucleoid een centrale rol inneemt.
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Samenvatting voor de leek
Dat elke menselijke cel een kern heeft met daarin erfelijke informatie van de vader en de moeder 
opgeslagen in het DNA, weet tegenwoordig bijna iedereen. Dat er daarnaast nog een aantal 
andere organellen of onderdelen in de cel aanwezig zijn, waaronder de mitochondriën, is ook 
iets wat op de middelbare school geleerd wordt. Mitochondriën zijn de energiecentrales van de 
cel. Dat deze hun eigen DNA hebben is minder bekend en hoe dat DNA georganiseerd is en aan 
dochtercellen wordt overgedragen, is iets waar wetenschappers nog onderzoek naar doen.
Elke cel bevat meerdere kopieën mitochondriëel DNA (mtDNA) wat alleen geërfd wordt van 
moederskant. Omdat er meerdere kopieën in de cellen aanwezig zijn kan het gebeuren dat 
sommige mtDNA moleculen een mutatie bevatten en andere niet. Dit is een situatie die wordt 
aangeduid als heteroplasmie, in tegenstelling tot de uniforme homoplastische situatie. Mutaties 
op mtDNA kunnen tot een breed scala aan ziekten leiden en het meest opmerkelijke is wel dat 
bijvoorbeeld de mutatie op locatie 3243 voornamelijk tot diabetes leidt maar ook tot ziekten 
van de zenuwen en de spieren, van de nieren en van het oog. Er zijn meerdere hypotheses over 
hoe een enkele mutatie tot verschillende ziektebeelden kan leiden en twee worden toegelicht 
in dit proefschrift. De ene variant gaat ervan uit dat door verschillen die ontstaan tijdens de 
celdeling, bij het verdelen van het mtDNA over de dochtercellen, het algemene energiedefect 
tot uiting komt in een specifiek orgaan. De andere variant gaat uit van specifieke signaalroutes 
die ervoor zorgen dat in de ene cel, bijvoorbeeld een insulineproducerende cel in de alvleesklier, 
effect optreedt en in andere cellen niet. 
Voor de eerste variant is het van belang om te weten hoe de verdeling van het mtDNA over de 
dochtercellen is georganiseerd. Voor alsnog werd ervan uitgegaan dat de mtDNA moleculen los in 
de cel liggen en dat de verdeling een willekeurige kansverdeling volgt. In hoofdstuk 2 en 3 wordt 
beschreven dat dit een erg onwaarschijnlijk model is en dat de mtDNA moleculen voornamelijk 
voorkomen in clusters die ook tijdens de celdeling blijven bestaan. In hoofdstuk 4 en 5 wordt de 
tweede variant bekeken door middel van een techniek die de invloed van mitochondriëel DNA 
op de werking van het kern DNA aan het licht brengt. Het lijkt erop dat als er op dit niveau een 
effect is dit te ingewikkeld is om een signaalroute te definiëren. Wel blijkt er op een ander niveau 
duidelijk effect te zijn, namelijk in de route voor het maken van eiwitten. Aangezien heel veel 
taken van de cel door eiwitten worden uitgevoerd is hiermee een aangrijpingspunt bloot gelegd 
voor het verklaren van ziekten veroorzaakt door mtDNA mutatie. 
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